Omega Healthcare Investors (OHI) 10-Q 7 Nov 13 2013 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Oct. 31, 2013
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'OMEGA HEALTHCARE INVESTORS INC	'
Entity Central Index Key	'0000888491	'
Trading Symbol	'ohi	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock Shares Outstanding	'	122,524,279
Document Type	'10-Q	'
Document Period End Date	30-Sep-13	'
Amendment Flag	'false	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Real estate properties	'	'	'	'
Land and buildings	$3,060,188	$3,038,553	'	'
Less accumulated depreciation	-675,685	-580,373	'	'
Real estate properties - net	2,384,503	2,458,180	'	'
Mortgage notes receivable - net	241,490	238,621	'	'
Real estate properties, total	2,625,993	2,696,801	'	'
Other investments - net	75,421	47,339	'	'
Total investments held, continuing operations	2,701,414	2,744,140	'	'
Assets held for sale - net	1,020	1,020	'	'
Total investments	2,702,434	2,745,160	'	'
Cash and cash equivalents	67,757	1,711	6,951	351
Restricted cash	28,781	36,660	'	'
Accounts receivable - net	142,426	125,180	'	'
Other assets	73,380	73,294	'	'
Total assets	3,014,778	2,982,005	'	'
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'	'	'
Revolving line of credit	'	158,000	'	'
Term loan	200,000	100,000	'	'
Secured borrowings	300,034	366,538	'	'
Unsecured borrowings - net	1,200,013	1,200,394	'	'
Accrued expenses and other liabilities	124,733	145,744	'	'
Total liabilities	1,824,780	1,970,676	'	'
Stockholders' equity:	'	'	'	'
Common stock $.10 par value 200,000 shares authorized - 119,518 shares as of September 30, 2013 and 112,393 as of December 31, 2012 issued and outstanding	11,952	11,239	'	'
Common stock - additional paid-in capital	1,876,609	1,664,855	'	'
Cumulative net earnings	879,443	754,128	'	'
Cumulative dividends paid	-1,578,006	-1,418,893	'	'
Total stockholders' equity	1,189,998	1,011,329	'	'
Total liabilities and stockholders' equity	$3,014,778	$2,982,005	'	'

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parentheticals) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, except Per Share data, unless otherwise specified
Statement Of Financial Position [Abstract]	'	'
Common stock, par value (in dollars per share)	$0.10	$0.10
Common stock, shares authorized	200,000	200,000
Common stock, shares issued	119,518	112,393
Common stock, shares outstanding	119,518	112,393

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS Unaudited (USD $)	0 Months Ended			3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jul. 16, 2013	Apr. 16, 2013	Jan. 16, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenue	'	'	'	'	'	'	'
Rental income	'	'	'	$93,837	$78,170	$280,015	$229,373
Mortgage interest income	'	'	'	7,289	7,677	22,070	22,417
Other investment income - net	'	'	'	2,175	1,238	5,341	3,533
Miscellaneous	'	'	'	'	23	151	125
Total operating revenues	'	'	'	103,301	87,108	307,577	255,448
Expenses	'	'	'	'	'	'	'
Depreciation and amortization	'	'	'	32,202	28,305	96,386	82,651
General and administrative	'	'	'	5,462	5,173	16,142	15,653
Acquisition costs	'	'	'	-9	483	134	686
Impairment loss on real estate properties	'	'	'	'	'	'	272
Provisions for uncollectible mortgages, notes and accounts receivable	'	'	'	2,321	'	2,386	'
Total operating expenses	'	'	'	39,976	33,961	115,048	99,262
Income before other income and expense	'	'	'	63,325	53,147	192,529	156,186
Other income (expense)	'	'	'	'	'	'	'
Interest income	'	'	'	3	6	20	22
Interest expense	'	'	'	-24,492	-24,050	-75,116	-71,026
Interest - amortization of deferred financing costs	'	'	'	-699	-673	-2,079	-1,970
Interest - refinancing gain (costs)	'	'	'	'	'	11,112	-5,410
Total other expense	'	'	'	-25,188	-24,717	-66,063	-78,384
Income before gain on assets sold	'	'	'	38,137	28,430	126,466	77,802
Gain (loss) on assets sold - net	'	'	'	'	1,689	-1,151	8,973
Net income available to common stockholders	'	'	'	$38,137	$30,119	$125,315	$86,775
Basic:	'	'	'	'	'	'	'
Net income	'	'	'	$0.32	$0.28	$1.08	$0.82
Diluted:	'	'	'	'	'	'	'
Net income	'	'	'	$0.32	$0.27	$1.08	$0.81
Dividends declared and paid per common share	$0.47	$0.46	$0.45	$0.47	$0.42	$1.38	$1.25
Weighted-average shares outstanding, basic	'	'	'	117,600	109,135	115,527	106,202
Weighted-average shares outstanding, diluted	'	'	'	118,462	109,667	116,335	106,570

CONSOLIDATED_STATEMENT_OF_STOC

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Unaudited (USD $)	Common Stock Par Value	Additional Paid-in Capital	Cumulative Net Earnings	Cumulative Dividends	Total
In Thousands, unless otherwise specified
Balance (112,393 common shares) at Dec. 31, 2012	$11,239	$1,664,855	$754,128	($1,418,893)	$1,011,329
Issuance of common stock:	'	'	'	'	'
Grant of restricted stock to company directors (15 shares at $30.33 per share)	2	-2	'	'	'
Amortization of restricted stock	'	4,350	'	'	4,350
Dividend reinvestment plan (1,677 shares at $28.53 per share)	168	47,653	'	'	47,821
Grant of stock as payment of directors fees (5 shares at an average of $30.93 per share)	'	137	'	'	137
Equity Shelf Program (5,428 shares at $30.19 per share, net of issuance costs)	543	159,616	'	'	160,159
Net income	'	'	125,315	'	125,315
Common dividends ($1.38 per share)	'	'	'	-159,113	-159,113
Balance (119,518 common shares) at Sep. 30, 2013	$11,952	$1,876,609	$879,443	($1,578,006)	$1,189,998

CONSOLIDATED_STATEMENT_OF_STOC1

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Unaudited (Parentheticals) (USD $)	9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013
Balance (in shares)	112,393
Dividend reinvestment plan, shares issued	1,677
Dividend reinvestment plan (in dollars per share)	$28.53
Equity Shelf Program (in shares)	5,428
Equity Shelf Program (in dollars per share)	$30.19
Common dividends, (in dollars per share)	$1.38
Balance (in shares)	119,518
Directors	'
Grant of restricted stock (in shares)	15
Grant of restricted stock (in dollars per share)	$30.33
Grant of stock as payment of directors fees (in shares)	5
Grant of stock as payment of directors fees (in dollars per share)	$30.93

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS Unaudited (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities	'	'
Net income	$125,315	$86,775
Adjustment to reconcile net income to cash provided by operating activities:	'	'
Depreciation and amortization	96,386	82,651
Impairment on real estate properties	'	272
Provision for uncollectible mortgages, notes and accounts receivable	2,386	'
Amortization of deferred financing and debt extinguishment (gain)/costs	-9,033	7,380
Restricted stock amortization expense	4,433	4,456
Loss (gain) on assets sold - net	1,151	-8,973
Amortization of acquired in-place leases - net	-3,821	-4,088
Other	'	-113
Change in operating assets and liabilities - net of amounts assumed/acquired:	'	'
Accounts receivable, net	-61	195
Straight-line rent receivables	-20,385	-19,745
Lease inducements	2,230	2,527
Effective yield receivable on mortgage notes	-1,416	-1,674
Other operating assets and liabilities	2,865	7,304
Net cash provided by operating activities	200,050	156,967
Cash flows from investing activities	'	'
Acquisition of real estate - net of liabilities assumed and escrows acquired	-2,400	-232,661
Deposit for proposed capital lease	-15,000	'
Placement of mortgage loans	-3,227	-7,126
Proceeds from sale of real estate investments	2,288	24,194
Capital improvements to real estate investments	-23,732	-20,106
Proceeds from other investments	4,113	11,821
Investments in other investments	-32,195	-4,671
Collection of mortgage principal	358	362
Net cash used in investing activities	-69,795	-228,187
Cash flows from financing activities	'	'
Proceeds from credit facility borrowings	101,000	272,000
Payments on credit facility borrowings	-259,000	-442,500
Proceeds from term loan	100,000	'
Receipts of other long-term borrowings	59,355	400,000
Payments of other long-term borrowings	-113,418	-189,657
Payments of financing related costs	-1,053	-13,150
Receipts from dividend reinvestment plan	47,821	106,132
Net proceeds from issuance of common stock	160,159	77,673
Dividends paid	-159,073	-132,678
Net cash (used in) provided by financing activities	-64,209	77,820
Increase in cash and cash equivalents	66,046	6,600
Cash and cash equivalents at beginning of period	1,711	351
Cash and cash equivalents at end of period	67,757	6,951
Interest paid during the period, net of amounts capitalized	$75,848	$70,123

BASIS_OF_PRESENTATION_AND_SIGN

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 1 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
	Business Overview
	Omega Healthcare Investors, Inc. (“Omega” or the “Company”) has one reportable segment consisting of investments in healthcare-related real estate properties.  Our core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (“SNFs”) located in the United States.  Our core portfolio consists of long-term leases and mortgage agreements.  All of our leases are “triple-net” leases, which require the tenants to pay all property-related expenses.  Our mortgage revenue derives from fixed-rate mortgage loans, which are secured by first mortgage liens on the underlying real estate and personal property of the mortgagor.
	Basis of Presentation
	The accompanying unaudited consolidated financial statements for Omega have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they do not include all of the information and notes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements.  In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included.  The results of operations for the interim periods reported herein are not necessarily indicative of results to be expected for the full year.  We have evaluated all subsequent events through the date of the filing of this Form 10-Q. These unaudited consolidated financial statements should be read in conjunction with the financial statements and the footnotes thereto included in our latest Annual Report on Form 10-K.
	Our consolidated financial statements include the accounts of (i) Omega, (ii) all direct and indirect wholly owned subsidiaries of Omega, and (iii) TC Healthcare, a variable interest entity (“VIE”) that we consolidate as the primary beneficiary.  All inter-company accounts and transactions have been eliminated in consolidation of the financial statements.
	Accounts Receivable
	Accounts receivable includes: contractual receivables, effective yield interest receivables, straight-line rent receivables and lease inducements, net of an estimated provision for losses related to uncollectible and disputed accounts.  Contractual receivables relate to the amounts currently owed to us under the terms of our lease and loan agreements.  Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement. Straight-line receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts currently due to us according to the contractual agreement.  Lease inducements result from value provided by us to the lessee at the inception or renewal of the lease and will be amortized as a reduction of rental revenue over the non cancellable lease term.
	On a quarterly basis, we review our accounts receivable to determine their collectability.  The determination of collectability of these assets requires significant judgment and is affected by several factors relating to the credit quality of our operators that we regularly monitor, including (i) payment history, (ii) the age of the contractual receivables, (iii) the current economic conditions and reimbursement environment, (iv) the ability of the tenant to perform under the terms of their lease and/or contractual loan agreements and (v) the value of the underlying collateral of the agreement.  If we determine collectability of any of our contractual receivables is at risk, we estimate the potential uncollectible amounts and provide an allowance.  In the case of a lease recognized on a straight-line basis or existence of lease inducements, we generally provide an allowance for straight-line accounts receivable and/or the lease inducements when certain conditions or indicators of adverse collectability are present.
	A summary of our net receivables by type is as follows:
		September 30,			December 31,
		2013			2012
		(in thousands)
	Contractual receivables	$	3,905		$	3,963
	Effective yield interest receivables		4,992			3,576
	Straight-line receivables		116,972			98,973
	Lease inducements		17,077			19,307
	Allowance		(520	)		(639	)
	Accounts receivable – net	$	142,426		$	125,180
	In August 2013, we entered into an agreement with one of our current operators and a new third party operator to transition 11 facilities from the current operator to the third party operator.  As a result of the transition, we evaluated the recoverability of the straight-line rent receivable associated with the current operator’s lease and recorded a $2.3 million provision for uncollectible accounts associated with straight-line receivables that were written-off.  (See Note 2 – Properties and Investments).
	We continuously evaluate the payment history and financial strength of our operators and have historically established allowance reserves for straight-line rent adjustments for operators that do not meet our requirements.  We consider factors such as payment history and the operator’s financial condition as well as current and future anticipated operating trends when evaluating whether to establish allowance reserves.

PROPERTIES_AND_INVESTMENTS

PROPERTIES AND INVESTMENTS	9 Months Ended
	Sep. 30, 2013
Real Estate [Abstract]	'
PROPERTIES AND INVESTMENTS	'
	NOTE 2 – PROPERTIES AND INVESTMENTS
	In the ordinary course of our business activities, we periodically evaluate investment opportunities and extend credit to customers.  We also regularly engage in lease and/or loan extensions and modifications. Additionally, we actively monitor and manage our investment portfolio with the objectives of improving credit quality and increasing investment returns.  In connection with our portfolio management, we may engage in various collection and foreclosure activities.
	If we acquire real estate pursuant to a foreclosure or bankruptcy proceeding, the assets will initially be included on the consolidated balance sheet at the lower of cost or estimated fair value.
	Leased Property
	Our leased real estate properties, represented by 417 SNFs, 16 assisted living facilities (“ALFs”) and 11 specialty facilities at September 30, 2013, are leased under provisions of single or master leases with initial terms typically ranging from 5 to 15 years, plus renewal options.  Substantially all of our leases contain provisions for specified annual increases over the rents of the prior year and are generally computed in one of three methods depending on specific provisions of each lease as follows: (i) a specific annual percentage increase over the prior year’s rent, generally 2.5%; (ii) an increase based on the change in pre-determined formulas from year to year (i.e., such as increases in the Consumer Price Index (“CPI”)); or (iii) specific dollar increases over prior years.  Under the terms of the leases, the lessee is responsible for all maintenance, repairs, taxes and insurance on the leased properties.
	Transition of 11 Arkansas Facilities to a New Operator
	On August 30, 2013, we transitioned 11 SNFs located in Arkansas that we previously leased to Advocat Inc. (now known as Diversicare Healthcare Services) to a new third party operator. The 11 facilities represent 1,084 operating beds. We amended the Advocat master lease to provide for reduced rent to reflect the transition of the 11 facilities to the new operator, and recorded a $2.3 million provision for uncollectible straight-line rent receivable. Simultaneously with the amendment to the Advocat master lease, we entered into a new master lease with the new third party operator of the 11 facilities. The new master lease expires on August 30, 2023 and includes fixed annual rent escalators.
	Commitment to Enter into a $525 Million Sale/Leaseback Transaction
	In September 2013, a wholly owned subsidiary of Omega committed to enter into a $525 million sale/leaseback transaction in connection with the proposed acquisition of Ark Holding Company, Inc. (“Ark Holding”) by 4 West Holdings, Inc. In connection with the closing of the proposed acquisition, a subsidiary of Omega will acquire title to 56 facilities currently operated by Ark Holding and lease them back to Ark Holding pursuant to a 50-year lease, with rental payments yielding 10.7% per annum over the term of the lease. The sale/leaseback transaction will be accounted for as a capital lease for accounting purposes and, consistent with that treatment, the tenant will have the right to purchase the facilities for a nominal price plus closing costs at the end of the lease. In addition, commencing in the 41st year of the lease, the tenant will have the right to prepay the remainder of its obligations thereunder for an amount equal to the sum of unamortized portion of the original $525 million investment by Omega, the net present value of the remaining payments under the lease, and closing costs. In the event the tenant exercises either of these options, we would have the right to purchase the properties for fair market value at the time. The sale/leaseback transaction is subject to the satisfaction of all the conditions to the closing of the proposed acquisition of Ark Holding, including obtaining certain consents and licenses, the absence of any event having a material adverse effect on Ark Holding since the date of the agreement, and the issuance of title insurance on the properties. In September 2013, we funded a $15.0 million deposit related to this potential transaction which is included in other assets as of September 30, 2013.
	Pro Forma Acquisition Results
	The facilities acquired in 2012 are included in our results of operations from the date of acquisition.  The following unaudited pro forma results of operations reflect the impact of the transactions as if they occurred on January 1, 2012.  For a list of the transactions, refer to Note 3 – Properties in our 2012 Form 10-K.  In the opinion of management, all significant necessary adjustments to reflect the effect of the acquisitions have been made.  The following pro forma information is not indicative of future operations.
		Pro Forma
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2013		2012		2013		2012
		(in thousands, except per share amounts, unaudited)
	Revenues	$	103,301	$	97,892	$	307,577	$	293,244
	Net income available to common stockholders	$	38,137	$	34,703	$	125,315	$	102,571
	Earnings per share – diluted:
	Net income available to common stockholders – as reported	$	0.32	$	0.27	$	1.08	$	0.81
	Net income available to common stockholders – pro forma	$	0.32	$	0.32	$	1.08	$	0.96
	Assets Sold or Assets Held for Sale
	Assets Sold
	In June 2013, we sold one facility in Texas for total cash proceeds of $2.2 million, resulting in a $1.2 million loss.  Also, in April 2013, we sold a parcel of undeveloped land to a third party for approximately $0.1 million.
	Assets Held for Sale
	At September 30, 2013, we had two SNFs and one parcel of land classified as held-for-sale with an aggregate net book value of approximately $1.0 million.
	Mortgage Notes Receivables
	Our mortgage notes receivables relate to 14 fixed-rate mortgages on 33 long-term care facilities.  The mortgage notes are secured by first mortgage liens on the borrowers’ underlying real estate and personal property.  The mortgage notes receivable relate to facilities located in five states, which are operated by five independent healthcare operating companies.  We monitor compliance with mortgages and when necessary have initiated collection, foreclosure and other proceedings with respect to certain outstanding loans.  As of September 30, 2013, none of our mortgages were in default or in foreclosure proceedings.  Where appropriate, the mortgage properties are generally cross-collateralized with the master lease agreement with the same operator.
	Mortgage interest income is recognized as earned over the terms of the related mortgage notes, using the effective yield method.  Allowances are provided against earned revenues from mortgage interest when collection of amounts due becomes questionable or when negotiations for restructurings of troubled operators lead to lower expectations regarding ultimate collection.  When collection is uncertain, mortgage interest income on impaired mortgage loans is recognized as received after taking into account application of security deposits.

OTHER_INVESTMENTS

OTHER INVESTMENTS	9 Months Ended
	Sep. 30, 2013
Receivables [Abstract]	'
OTHER INVESTMENTS	'
	NOTE 3 – OTHER INVESTMENTS
	A summary of our other investments is as follows:
			September 30,			December 31,
			2013			2012
			(in thousands)
	Other Investment note due 2015		$	2,368		$	2,518
	Other Investment notes due 2021 - 2023			13,217			9,775
	Other Investment note due 2013			551			1,018
	Other Investment note due 2014			250			812
	$28.0 Million Other Investment note due 2017			24,500			26,500
	$2.5 Million Other Investment note due 2014			306			-
	$6.0 Million Other Investment note due 2013			5,439			3,450
	Other Investment note due 2013			-			261
	$1.3 Million Other Investment note due 2017			1,300			425
	$25.0 Million Other Investment note due 2017			24,910			-
	Notes receivable, gross(1)			72,841			44,759
	Allowance for loss on notes receivable			(1,977	)		(1,977	)
	Notes receivable, net			70,864			42,782
	Marketable securities and other			4,557			4,557
	Total other investments		$	75,421		$	47,339
	-1	The majority of these notes bear interest at approximately 10% annually.
	$25 Million Other Investment Note due 2017
	In May 2013, we invested $24.9 million in a mezzanine loan with a third party.  The loan bears interest at 12% per annum and matures in December 2017.

CONCENTRATION_OF_RISK

CONCENTRATION OF RISK	9 Months Ended
	Sep. 30, 2013
Risks and Uncertainties [Abstract]	'
CONCENTRATION OF RISK	'
	NOTE 4 – CONCENTRATION OF RISK
	As of September 30, 2013, our portfolio of real estate investments consisted of 480 healthcare facilities, located in 34 states and operated by 48 third-party operators.  Our gross investment in these facilities, net of impairments and before reserve for uncollectible loans, totaled approximately $3.3 billion at September 30, 2013, with approximately 99% of our real estate investments related to long-term care facilities.  Our portfolio is made up of 417 SNFs, 16 ALFs, 11 specialty facilities, fixed rate mortgages on 33 SNFs and three SNFs that are closed/held-for-sale.  At September 30, 2013, we also held miscellaneous investments of approximately $75.4 million, consisting primarily of secured loans to third-party operators of our facilities.
	At September 30, 2013 we had investments with two operators and/or managers that exceeded 10% of our total investment: (i) Genesis Healthcare (“Genesis”) (11%), and (ii) CommuniCare Health Services, Inc. (“CommuniCare”) (10%).  The three states in which we had our highest concentration of investments were Florida (18%), Ohio (11%) and Indiana (10%) at September 30, 2013.
	For the three-month period ended September 30, 2013, our revenues from operations totaled $103.3 million, of which approximately $13.8 million were from Genesis (13%) and $11.0 million were from CommuniCare (11%).  No other operator generated more than 10% of our revenues from operations for the three-month period ended September 30, 2013.
	For the nine-month period ended September 30, 2013, our revenues from operations totaled $307.6 million, of which approximately $41.4 million were from Genesis (13%) and $33.1 million were from CommuniCare (11%).  No other operator generated more than 10% of our revenues from operations for the nine-month period ended September 30, 2013.

DIVIDENDS

DIVIDENDS	9 Months Ended
	Sep. 30, 2013
Dividends [Abstract]	'
DIVIDENDS	'
	NOTE 5 – DIVIDENDS
	On October 15, 2013, the Board of Directors declared a common stock dividend of $0.48 per share, increasing the quarterly common dividend by $0.01 per share over the previous quarter.  The common dividends are to be paid November 15, 2013 to common stockholders of record on October 31, 2013.
	On July 16, 2013, the Board of Directors declared a common stock dividend of $0.47 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter, which was paid August 15, 2013 to common stockholders of record on July 31, 2013.
	On April 16, 2013, the Board of Directors declared a common stock dividend of $0.46 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter, which was paid May 15, 2013 to common stockholders of record on April 30, 2013.
	On January 16, 2013, the Board of Directors declared a common stock dividend of $0.45 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter, which was paid February 15, 2013 to common stockholders of record on January 31, 2013.

TAXES

TAXES	9 Months Ended
	Sep. 30, 2013
Income Tax Disclosure [Abstract]	'
TAXES	'
	NOTE 6 – TAXES
	So long as we qualify as a real estate investment trust (“REIT”) under the Internal Revenue Code (the “Code”), we generally will not be subject to federal income taxes on the REIT taxable income that we distribute to stockholders, subject to certain exceptions.  On a quarterly and annual basis, we test our compliance within the REIT taxation rules to ensure that we were in compliance with the rules.
	Subject to the limitation under the REIT asset test rules, we are permitted to own up to 100% of the stock of one or more taxable REIT subsidiaries (“TRSs”).  Currently, we have one TRS that is taxable as a corporation and pays federal, state and local income tax on its net income at the applicable corporate rates.  As of September 30, 2013, the TRS had a net operating loss carry-forward of $1.0 million.  The loss carry-forward is fully reserved with a valuation allowance as of September 30, 2013.

STOCKBASED_COMPENSATION

STOCK-BASED COMPENSATION	9 Months Ended
	Sep. 30, 2013
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]	'
STOCK-BASED COMPENSATION	'
	NOTE 7 – STOCK-BASED COMPENSATION
	On June 6, 2013, at our Company’s Annual Meeting, our stockholders approved the 2013 Stock Incentive Plan (the “2013 Plan”), which amended and restated the Company’s 2004 Stock Incentive Plan.  The 2013 Plan is a comprehensive incentive compensation plan that allows for various types of equity-based compensation, including restricted stock units (including performance-based restricted stock units), stock awards, deferred restricted stock units, incentive stock options, non-qualified stock options, stock appreciation rights, dividend equivalent rights and certain cash-based awards (including performance-based cash awards).  The 2013 Plan increased the number of shares reserved for issuance for compensation purposes by 3,000,000.
	The following is a summary of our stock-based compensation expense for the three- and nine- month periods ended September 30, 2013 and 2012, respectively:
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2013		2012		2013		2012
		(in thousands)
	Stock-based compensation expense	$	1,509	$	1,485	$	4,433	$	4,456
	Stock Awards
	Effective January 2011, we granted 428,503 shares of restricted stock and 496,977 performance restricted stock units (“PRSUs”) to six employees. In each of January 2012 and 2013, we granted an additional 124,244 PRSUs to six employees.
	Restricted Stock Awards
	The restricted stock awards vest 100% on December 31, 2013, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.  As of September 30, 2013, no shares of restricted stock have vested under these restricted stock awards.
	Performance Restricted Stock Units
	Effective January 1, 2011, we awarded three types of PRSUs to the six employees: (i) 124,244 annual total shareholder return (“TSR”) PRSUs for the year ended December 31, 2011 (“2011 Annual TSR PRSUs”); (ii) 279,550 multi-year absolute TSR PRSUs and (iii) 93,183 multi-year relative TSR PRSUs.  On January 1, 2012 and 2013, we awarded to the six employees 124,244 annual TSR PRSUs for the year ended December 31, 2012 and 2013 (the “2012 Annual TSR PRSUs” and the “2013 Annual TSR PRSUs”).
	Annual TSR PRSUs
	The number of shares earned under the annual TSR PRSUs depends generally on the level of achievement of TSR for the year.  The annual TSR PRSUs vest on December 31 of the year, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.  The 2011 Annual TSR PRSUs were forfeited because the required TSR for 2011 was not achieved.  The performance requirement for the 2012 Annual TSR PRSUs was achieved and the 124,244 shares vested and were distributed to the employees at December 31, 2012.  As of September 30, 2013, the 2013 annual TSR PRSUs have not been earned.
	Multi-year Absolute TSR PRSUs
	The number of shares earned under the multi-year absolute TSR PRSUs depends generally on the level of achievement of TSR for the three-years ending December 31, 2013.  The multi-year absolute TSR PRSUs vest 25% on the last day of each calendar quarter in 2014, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	Multi-year Relative TSR PRSUs
	The number of shares earned under the multi-year relative TSR PRSUs depends generally on the level of achievement of TSR relative to other real estate investment trusts in the MSCI U.S. REIT Index for the three-years ending December 31, 2013.  The multi-year relative TSR PRSUs vest 25% on the last day of each calendar quarter in 2014, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	The PRSU awards have varying degrees of performance requirements to achieve vesting, and each PRSU award represents the right to a variable number of shares of common stock and related dividend equivalents based on dividends paid to stockholders during the applicable performance period.
	As of September 30, 2013, none of the multi-year PRSUs are vested or earned.
	The following table summarizes our total unrecognized compensation cost as of September 30, 2013 associated with outstanding restricted stock and PRSU awards to employees:
		Shares/ Units		Grant Date		Total		Weighted		Unrecognized
				Average Fair		Compensation		Average		Compensation
				Value Per		Cost		Period of		Cost
				Unit/ Share		(in millions)		Expense Recognition		(in millions)
								(in months)
	Restricted stock		428,503	$	22.44	$	9.6		36	$	0.8
	2013 Annual PRSUs		124,244	$	8.92		1.1		12		0.3
	Multi-year absolute TSR PRSUs		279,550	$	11.06		3.1		44		0.7
	Multi-year relative TSR PRSUs		93,183	$	12.26		1.1		44		0.2
	Total		925,480	$	14.93	$	14.9			$	2
	We used a Monte Carlo model to estimate the fair value for PRSUs granted to the employees.
	Director Restricted Stock Grants
	As of September 30, 2013, we had 43,457 shares of restricted stock outstanding to directors.  The directors’ restricted shares are scheduled to vest over the next three years.  As of September 30, 2013, the unrecognized compensation cost associated with outstanding director restricted stock grants is approximately $0.5 million.

FINANCING_ACTIVITIES_AND_BORRO

FINANCING ACTIVITIES AND BORROWING ARRANGEMENTS	9 Months Ended
	Sep. 30, 2013
Debt Disclosure [Abstract]	'
FINANCING ACTIVITIES AND BORROWING ARRANGEMENTS	'
	NOTE 8 – FINANCING ACTIVITIES AND BORROWING ARRANGEMENTS
	Secured and Unsecured Borrowings
	The following is a summary of our long-term borrowings:
					Current			September 30,		December 31,
			Maturity		Rate			2013		2012
								(in thousands)
	Secured borrowings:
	HUD mortgages assumed June 2010			2036 - 2040		-		$	—	$	62,921
	HUD mortgages assumed June 2010 (1)			2040 - 2045		4.85	%		129,209		130,887
	HUD mortgages assumed October 2011 (1)			2036 - 2040		4.87	%		31,359		31,991
	HUD mortgages assumed December 2011(1)			2044		3.06	%		58,880		58,884
	HUD mortgages assumed December 2012(1)			2031 - 2045		5.5	%		80,586		81,855
	Total secured borrowings								300,034		366,538
	Unsecured borrowings:
	Revolving line of credit			2016		-		$	—	$	158,000
	Term loan			2017		1.93	%		200,000		100,000
									200,000		258,000
	2020 notes			2020		7.5	%		200,000		200,000
	2022 notes			2022		6.75	%		575,000		575,000
	2024 notes			2024		5.875	%		400,000		400,000
	Subordinated debt			2021		9	%		20,930		21,049
									1,195,930		1,196,049
	Premium - net								4,083		4,345
	Total unsecured borrowings								1,400,013		1,458,394
	Totals – net							$	1,700,047	$	1,824,932
		-1	Reflects the weighted average annual interest rate on the mortgages.
	Certain of our other secured and unsecured borrowings are subject to customary affirmative and negative covenants, including financial covenants.  As of December 31, 2012 and September 30, 2013, we were in compliance with all affirmative and negative covenants, including financial covenants, for our secured and unsecured borrowings.
	Bank Credit Agreements
	We have a $700 million unsecured credit facility that we entered into on December 6, 2012, comprised of a $500 million unsecured revolving credit facility  (the “2012 Revolving Credit Facility”) and a $200 million unsecured term loan (the “2012 Term Loan Facility” and, together with the 2012 Revolving Credit Facility, collectively, the “2012 Credit Facilities”).
	The 2012 Credit Facilities include an “accordion feature” that permits us to expand our borrowing capacity thereunder by a combined $300 million, to a total of $1 billion.
	At September 30, 2013, we had no outstanding amount under the 2012 Revolving Credit Facility, and no letters of credit outstanding, leaving availability of $500 million.  The 2012 Revolving Credit Facility matures on December 6, 2016, with an option by us to extend the maturity one additional year.  The 2012 Revolving Credit Facility is priced at LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 190 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings, plus a facility fee based on the same ratings (initially 30 basis points, with a range of 15 to 45 basis points).
	At September 30, 2013, the full $200 million was outstanding under the 2012 Term Loan Facility.  The 2012 Term Loan Facility is also priced at LIBOR plus an applicable percentage (beginning at 175 basis points, with a range of 110 to 230 basis points) based our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings.  The 2012 Term Loan Facility matures on December 6, 2017.
	HUD Loans Payoff
	On May 31, 2013, we paid approximately $51.0 million to retire 11 mortgages guaranteed by U.S. Department of Housing and Urban Development (“HUD”) that were assumed in connection with our acquisition of certain subsidiaries of CapitalSource in June 2010.  The retirement of the 11 HUD mortgages resulted in a net gain of approximately $11.1 million.  The net gain included the write-off of approximately $11.3 million related to the premium for recording the debt at fair value at the time of the transaction offset by a prepayment fee of approximately $0.2 million.
	HUD Mortgage Debt Refinancing
	On March 26, 2013, we refinanced existing HUD mortgage debt on 12 properties in Arkansas for approximately $59.4 million including closing costs that were added to the outstanding balance.  The annual interest rate for the refinanced debt decreased from 5.55% to approximately 3.06%, with the term of the refinanced mortgages remaining unchanged.  For the three months ended March 31, 2013, we paid off a total of $58.9 million, including routine principal payments on the 12 Arkansas mortgage debts.
	$250 Million Equity Shelf Program
	On March 18, 2013, we entered into separate Equity Distribution Agreements (collectively, the “2013 Agreements”) to sell shares of our common stock having an aggregate gross sales price of up to $250 million (the “2013 ESP”) with several financial institutions, each as a sales agent and/or principal (collectively, the “Managers”).  Under the terms of the 2013 Agreements, we may sell shares of our common stock, from time to time, through or to the Managers having an aggregate gross sales price of up to $250 million.  Sales of the shares will be made by means of ordinary brokers’ transactions on the New York Stock Exchange at market prices, or as otherwise agreed with the applicable Manager.  We will pay each Manager compensation for sales of the shares equal to 2% of the gross sales price per share of shares sold through such Manager under the applicable 2013 Agreement.  We are not obligated to sell and the Managers are not obligated to buy or sell any shares under the 2013 Agreements.  No assurance can be given that we will sell any shares under the 2013 Agreements, or, if we do, as to the price or amount of shares that we sell, or the dates when such sales will take place.
	For the three months ended September 30, 2013, we sold 2.1 million shares under the 2013 ESP, at an average price of $29.42 per share, generating gross proceeds of approximately $63.2 million, before $1.3 million of commissions.  For the nine months ended September 30, 2013, we sold approximately 4.4 million shares under the 2013 ESP, at an average price of $30.61 per share, generating gross proceeds of approximately $136.0 million, before $2.7 million of commissions.
	Termination of $245 Million Equity Shelf Program
	On March 18, 2013, we terminated our $245 million Equity Shelf Program (the “2012 ESP”) that we entered into with several financial institutions on June 19, 2012.  For the three months ended March 31, 2013, we issued approximately 1.0 million shares under the 2012 ESP at an average price of $28.29 per share, generating gross proceeds of approximately $27.8 million, before $0.6 million of commissions.
	Since inception of the 2012 ESP, we have sold a total of 3.6 million shares of common stock generating total gross proceeds of $91.4 million under the program, before $1.9 million of commissions.  As a result of the termination of the 2012 ESP, no additional shares were issued under the 2012 ESP.
	Dividend Reinvestment and Common Stock Purchase Plan
	For the three-month period ended September 30, 2013, approximately 0.2 million shares of our common stock at an average price of $29.03 per share were issued through our Dividend Reinvestment and Common Stock Purchase Program for net proceeds of approximately $6.2 million.  For the nine-month period ended September 30, 2013, approximately 1.7 million shares of our common stock at an average price of $28.53 per share were issued through our Dividend Reinvestment and Common Stock Purchase Program for net proceeds of approximately $47.8 million.

FINANCIAL_INSTRUMENTS

FINANCIAL INSTRUMENTS	9 Months Ended
	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
FINANCIAL INSTRUMENTS	'
	NOTE 9 – FINANCIAL INSTRUMENTS
	At September 30, 2013 and December 31, 2012, the carrying amounts and fair values of our financial instruments were as follows:
			30-Sep-13				31-Dec-12
			Carrying		Fair		Carrying		Fair
			Amount		Value		Amount		Value
	Assets:		(in thousands)
	Cash and cash equivalents		$	67,757	$	67,757	$	1,711	$	1,711
	Restricted cash			28,781		28,781		36,660		36,660
	Mortgage notes receivable – net			241,490		240,013		238,621		235,705
	Other investments – net			75,421		72,820		47,339		44,077
	Totals		$	413,449	$	409,371	$	324,331	$	318,153
	Liabilities:
	Revolving line of credit		$	—	$	—	$	158,000	$	158,000
	Term loan			200,000		200,000		100,000		100,000
	7.50% Notes due 2020 – net			197,805		246,304		197,546		252,363
	6.75% Notes due 2022 – net			581,278		709,601		581,799		724,240
	5.875% Notes due 2024 – net			400,000		401,492		400,000		441,761
	HUD debt			300,034		335,745		366,538		433,803
	Subordinated debt			20,930		27,153		21,049		27,896
	Totals		$	1,700,047	$	1,920,295	$	1,824,932	$	2,138,063
	Fair value estimates are subjective in nature and are dependent on a number of important assumptions, including estimates of future cash flows, risks, discount rates and relevant comparable market information associated with each financial instrument (see Note 2 – Summary of Significant Accounting Policies in our 2012 Annual Report on Form 10-K).  The use of different market assumptions and estimation methodologies may have a material effect on the reported estimated fair value amounts.
	The following methods and assumptions were used in estimating fair value disclosures for financial instruments.
		●	Cash and cash equivalents and restricted cash:  The carrying amount of cash and cash equivalents and restricted cash reported in the balance sheet approximates fair value because of the short maturity of these instruments (i.e., less than 90 days) (Level 1).
		●	Mortgage notes receivable:  The fair values of the mortgage notes receivables are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3).
		●	Other investments:  Other investments are primarily comprised of: (i) notes receivable and (ii) an investment in a redeemable non-convertible preferred security of an unconsolidated business accounted for using the cost method of accounting.  The fair values of notes receivable are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3).  The fair value of the investment in the unconsolidated business is estimated using quoted market value and considers the terms of the underlying arrangement (Level 3).
		●	Revolving line of credit and term loan:  The fair value of our borrowings under variable rate agreements are estimated using an expected present value technique based on expected cash flows discounted using the current market rates (Level 2).
		●	Senior notes and other long-term borrowings:  The fair value of our borrowings under fixed rate agreements are estimated based on open market trading activity provided by a third party (Level 2).

LITIGATION

LITIGATION	9 Months Ended
	Sep. 30, 2013
Commitments and Contingencies Disclosure [Abstract]	'
LITIGATION	'
	NOTE 10 – LITIGATION
	We are subject to various legal proceedings, claims and other actions arising out of the normal course of business. While any legal proceeding or claim has an element of uncertainty, management believes that the outcome of each lawsuit, claim or legal proceeding that is pending or threatened, or all of them combined, will not have a material adverse effect on our consolidated financial position or results of operations.

EARNINGS_PER_SHARE

EARNINGS PER SHARE	9 Months Ended
	Sep. 30, 2013
Net Income Available To Common Per Share	'
EARNINGS PER SHARE	'
	NOTE 11 – EARNINGS PER SHARE
	The computation of basic earnings per share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of shares of common stock outstanding during the relevant period.  Diluted EPS is computed using the treasury stock method, which is net income available to common stockholders divided by the total weighted-average number of common outstanding shares plus the effect of dilutive common equivalent shares during the respective period.  Dilutive common shares reflect the assumed issuance of additional common shares pursuant to certain of our share-based compensation plans, including stock options, restricted stock and performance restricted stock units.
	The following tables set forth the computation of basic and diluted earnings per share:
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2013		2012		2013		2012
		(in thousands, except per share amounts)
	Numerator:
	Net income	$	38,137	$	30,119	$	125,315	$	86,775
	Numerator for net income available to common per share - basic and diluted	$	38,137	$	30,119	$	125,315	$	86,775
	Denominator:
	Denominator for basic earnings per share		117,600		109,135		115,527		106,202
	Effect of dilutive securities:
	Restricted stock		823		511		774		350
	Deferred stock		39		21		34		18
	Denominator for diluted earnings per share		118,462		109,667		116,335		106,570
	Earnings per share – basic:
	Net income – basic	$	0.32	$	0.28	$	1.08	$	0.82
	Earnings per share – diluted:
	Net income – diluted	$	0.32	$	0.27	$	1.08	$	0.81

CONSOLIDATING_FINANCIAL_STATEM

CONSOLIDATING FINANCIAL STATEMENTS	9 Months Ended
	Sep. 30, 2013
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]	'
CONSOLIDATING FINANCIAL STATEMENTS	'
	NOTE 12 – CONSOLIDATING FINANCIAL STATEMENTS
	As of September 30, 2013, we had outstanding (i) $200 million 7.5% Senior Notes due 2020, (ii) $575 million 6.75% Senior Notes due 2022 and (iii) $400 million 5.875% Senior Notes due 2024, which we collectively refer to as the Senior Notes. The Senior Notes are fully and unconditionally guaranteed, jointly and severally, by each of our subsidiaries that guarantee other indebtedness of Omega or any of the subsidiary guarantors. All of our subsidiaries that guarantee the Senior Notes also guarantee the 2012 Credit Facilities. Any subsidiary that we properly designate as an “unrestricted subsidiary” under the indentures governing the Senior Notes will not provide guarantees of the Senior Notes or of our 2012 Credit Facilities.
	As of and prior to March 31, 2010, the non-guarantor subsidiaries were minor and insignificant. On June 29, 2010, we designated as “unrestricted subsidiaries” the 39 subsidiaries we acquired from CapitalSource subject to HUD indebtedness. During the fourth quarter of 2011, we designated as “unrestricted subsidiaries” 20 subsidiaries we acquired subject to HUD indebtedness, of which five subsidiaries were removed in July 2012 due to the retirement of the HUD related mortgages. During the fourth quarter of 2012, we designated as “unrestricted subsidiaries” eight subsidiaries we acquired subject to HUD indebtedness. In July 2013, we removed 11 subsidiaries due to the retirement of the HUD related debt.
	For the nine months ended September 30, 2013 and 2012, the operating cash flow of the non-guarantor subsidiaries approximated net income of the non-guarantor subsidiaries, adjusted for depreciation and amortization expense.  On March 26, 2013, the non-guarantor subsidiaries refinanced existing HUD mortgage debt on 12 properties in Arkansas for approximately $59.4 million. The refinanced amount included $58.9 million related to retiring the old HUD debt and $0.5 million of closing costs that were added to the new (refinanced) HUD debt.  On May 31, 2013, we retired 11 HUD mortgages totaling $62.3 million ($51.0 million related to the outstanding principal of the 11 HUD mortgages and $11.3 million related to the unamortized premium for marking the debt to market on the date the debt was assumed and $0.2 million in prepayment fees).
	In addition, the non-guarantor subsidiaries also made $3.4 million of routine principal payments during the nine months ended September 30, 2013. For the nine-month period ended September 30, 2012, the non-guarantor subsidiaries did not engage in investing or financing activities other than the principal payment of $2.3 million for the HUD mortgages on the facilities owned by the non-guarantor subsidiaries. All of the subsidiary guarantors of our outstanding Senior Notes and 2012 Credit Facilities, and all of our non-guarantor subsidiaries, are 100% owned by Omega.
	The following summarized condensed consolidating financial information segregates the financial information of the non-guarantor subsidiaries from the financial information of Omega Healthcare Investors, Inc. and the subsidiary guarantors under the Senior Notes.  The results and financial position of acquired entities are included from the dates of their respective acquisitions.
	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING BALANCE SHEETS
	Unaudited
	(in thousands, except per share amounts)
		30-Sep-13
		Issuer & Subsidiary Guarantors			Non-Guarantor Subsidiaries			Elimination Company			Consolidated
	ASSETS
	Real estate properties
	Land and buildings	$	2,602,688		$	457,500		$	-		$	3,060,188
	Less accumulated depreciation		(627,301	)		(48,384	)		-			(675,685	)
	Real estate properties – net		1,975,387			409,116			-			2,384,503
	Mortgage notes receivable – net		241,490			-			-			241,490
			2,216,877			409,116			-			2,625,993
	Other investments – net		75,421			-			-			75,421
			2,292,298			409,116			-			2,701,414
	Assets held for sale – net		1,020			-			-			1,020
	Total investments		2,293,318			409,116			-			2,702,434
	Cash and cash equivalents		67,757			-			-			67,757
	Restricted cash		6,755			22,026			-			28,781
	Accounts receivable – net		136,101			6,325			-			142,426
	Investment in affiliates		107,535			-			(107,535	)		-
	Other assets		46,829			26,551			-			73,380
	Total assets	$	2,658,295		$	464,018		$	(107,535	)	$	3,014,778
	LIABILITIES AND STOCKHOLDERS’ EQUITY
	Revolving line of credit	$	-		$	-		$	-		$	-
	Term loan		200,000			-			-			200,000
	Secured borrowings		-			300,034			-			300,034
	Unsecured borrowings – net		1,179,083			20,930			-			1,200,013
	Accrued expenses and other liabilities		89,214			35,519			-			124,733
	Intercompany payable		-			85,438			(85,438	)		-
	Total liabilities		1,468,297			441,921			(85,438	)		1,824,780
	Stockholders’ equity:
	Common stock		11,952			-			-			11,952
	Common stock – additional paid-in capital		1,876,609			-			-			1,876,609
	Cumulative net earnings		879,443			22,097			(22,097	)		879,443
	Cumulative dividends paid		(1,578,006	)		-			-			(1,578,006	)
	Total stockholders’ equity		1,189,998			22,097			(22,097	)		1,189,998
	Total liabilities and stockholders’ equity	$	2,658,295		$	464,018			(107,535	)	$	3,014,778
	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING BALANCE SHEETS
	(in thousands, except per share amounts)
		31-Dec-12
					Non – Guarantor Subsidiaries			Elimination Company
		Issuer & Subsidiary									Consolidated
		Guarantors
	ASSETS
	Real estate properties
	Land and buildings	$	2,580,977		$	457,576		$	—		$	3,038,553
	Less accumulated depreciation		(547,489	)		(32,884	)		—			(580,373	)
	Real estate properties – net		2,033,488			424,692			—			2,458,180
	Mortgage notes receivable – net		238,621			—			—			238,621
			2,272,109			424,692			—			2,696,801
	Other investments – net		47,339			—			—			47,339
			2,319,448			424,692			—			2,744,140
	Assets held for sale – net		1,020			—			—			1,020
	Total investments		2,320,468			424,692			—			2,745,160
	Cash and cash equivalents		1,711			—			—			1,711
Restricted cash		10,095			26,565			—			36,660
Accounts receivable – net		121,488			3,692			—			125,180
Investment in affiliates		115,835			—			(115,835	)		—
Other assets		49,153			24,141			—			73,294
Total assets	$	2,618,750		$	479,090			(115,835	)	$	2,982,005
LIABILITIES AND STOCKHOLDERS’ EQUITY
Revolving line of credit	$	158,000		$	—		$	—		$	158,000
Term loan		100,000			—			—			100,000
Secured borrowings		62,921			303,617			—			366,538
Unsecured borrowings – net		1,179,345			21,049			—			1,200,394
Accrued expenses and other liabilities		107,155			38,589			—			145,744
Intercompany payable		—			104,040			(104,040	)		—
Total liabilities		1,607,421			467,295			(104,040	)		1,970,676
Stockholders’ equity:
Common stock		11,239			—			—			11,239
Common stock – additional paid-in capital		1,664,855			—			—			1,664,855
Cumulative net earnings		754,128			11,795			(11,795	)		754,128
Cumulative dividends paid		(1,418,893	)		—			—			(1,418,893	)
Total stockholders’ equity		1,011,329			11,795			(11,795	)		1,011,329
Total liabilities and stockholders’ equity	$	2,618,750		$	479,090		$	(115,835	)	$	2,982,005
OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATING STATEMENTS OF OPERATIONS
Unaudited
(in thousands, except per share amounts)
													Nine Months Ended September 30, 2013
	Three Months Ended September 30, 2013
				Non – Guarantor Subsidiaries						Consolidated			Issuer & Subsidiary Guarantors			Non – Guarantor Subsidiaries						Consolidated
	Issuer & Subsidiary Guarantors
							Elimination												Elimination
Revenue
Rental income	$	81,289		$	12,548		$	-		$	93,837		$	242,253		$	37,762		$	-		$	280,015
Mortgage interest income		7,289			-			-			7,289			22,070			-			-			22,070
Other investment income – net		2,175			-			-			2,175			5,341			-			-			5,341
Miscellaneous		-			-			-			-			151			-			-			151
Total operating revenues		90,753			12,548			-			103,301			269,815			37,762			-			307,577
Expenses
Depreciation and amortization		27,034			5,168			-			32,202			80,885			15,501			-			96,386
General and administrative		5,372			90			-			5,462			15,859			283			-			16,142
Acquisition costs		(9	)		-			-			(9	)		134			-			-			134
Provision for uncollectible mortgages, notes and accounts receivable		2,321			-			-			2,321			2,386			-			-			2,386
Total operating expenses		34,718			5,258			-			39,976			99,264			15,784			-			115,048
Income before other income and expense		56,035			7,290			-			63,325			170,551			21,978			-			192,529
Other income (expense):
Interest income		(4	)		7			-			3			(1	)		21			-			20
Interest expense		(20,725	)		(3,767	)		-			(24,492	)		(63,429	)		(11,687	)		-			(75,116	)
Interest – amortization of deferred financing costs		(694	)		(5	)		-			(699	)		(2,069	)		(10	)		-			(2,079	)
Interest – refinancing gain (costs)		-			-			-			-			11,112			-			-			11,112
Equity in earnings		3,525			-			(3,525	)		-			10,302			-			(10,302	)		-
Total other expense		(17,898	)		(3,765	)		(3,525	)		(25,188	)		(44,085	)		(11,676	)		(10,302	)		(66,063	)
Income before gain on assets sold		38,137			3,525			(3,525	)		38,137			126,466			10,302			(10,302	)		126,466
Loss on assets sold – net		-			-			-			-			(1,151	)		-			-			(1,151	)
Net income (loss) available to common stockholders	$	38,137		$	3,525		$	(3,525	)	$	38,137		$	125,315		$	10,302		$	(10,302	)	$	125,315
OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATING STATEMENTS OF OPERATIONS
Unaudited
(in thousands, except per share amounts)
													Nine Months Ended September 30, 2012
	Three Months Ended September 30, 2012
				Non – Guarantor Subsidiaries						Consolidated			Issuer & Subsidiary Guarantors			Non – Guarantor Subsidiaries						Consolidated
	Issuer & Subsidiary Guarantors						Elimination												Elimination
							Company												Company
Revenue
Rental income	$	69,092		$	9,078		$	-		$	78,170		$	202,008		$	27,365		$	-		$	229,373
Mortgage interest income		7,677			-			-			7,677			22,417			-			-			22,417
Other investment income – net		1,238			-			-			1,238			3,533			-			-			3,533
Miscellaneous		23			-			-			23			125			-			-			125
Total operating revenues		78,030			9,078			-			87,108			228,083			27,365			-			255,448
Expenses
Depreciation and amortization		24,220			4,085			-			28,305			70,457			12,194			-			82,651
General and administrative		5,090			83			-			5,173			15,390			263			-			15,653
Acquisition costs		483			-			-			483			686			-			-			686
Impairment loss on real estate properties		-			-			-			-			272			-			-			272
Total operating expenses		29,793			4,168			-			33,961			86,805			12,457			-			99,262
Income before other income and expense		48,237			4,910			-			53,147			141,278			14,908			-			156,186
Other income (expense):
Interest income		-			6			-			6			4			18			-			22
Interest expense		(20,602	)		(3,448	)		-			(24,050	)		(61,290	)		(9,736	)		-			(71,026	)
Interest – amortization of deferred financing costs		(673	)		-			-			(673	)		(1,970	)		-			-			(1,970	)
Interest – refinancing gain (costs)		-			-			-			-			(5,410	)		-			-			(5,410	)
Equity in earnings		1,468			-			(1,468	)		-			5,190			-			(5,190	)		-
Total other expense		(19,807	)		(3,442	)		(1,468	)		(24,717	)		(63,476	)		(9,718	)		(5,190	)		(78,384	)
Income before gain on assets sold		28,430			1,468			(1,468	)		28,430			77,802			5,190			(5,190	)		77,802
Gain on assets sold – net		1,689			-			-			1,689			8,973			-			-			8,973
Net income (loss) available to common stockholders	$	30,119		$	1,468		$	(1,468	)	$	30,119		$	86,775		$	5,190		$	(5,190	)	$	86,775

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2013
Subsequent Events [Abstract]	'
SUBSEQUENT EVENTS	'
	NOTE 13 – SUBSEQUENT EVENTS
	$33 Million of New Investments in Florida in October 2013
	In October 2013, we completed two separate acquisitions with two existing operators totaling $33 million. The acquisitions consisted of 1 ALF in Florida totaling 97 beds and 4 SNFs located in Indiana totaling 384 beds. These facilities were added to existing master leases.
	2.875 Million Shares of Common Stock Offering
	On October 7, 2013, we sold 2,875,000 shares of common stock in an underwritten public offering at an offering price of $30 per share before underwriting discounts and expenses. Our total net proceeds from the offering, after underwriting discounts and expenses were approximately $84.5 million.

BASIS_OF_PRESENTATION_AND_SIGN1

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2013
Organization, Consolidation and Presentation Of Financial Statements [Abstract]	'
Basis of Presentation	'
	Basis of Presentation
	The accompanying unaudited consolidated financial statements for Omega have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X.  Accordingly, they do not include all of the information and notes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements.  In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included.  The results of operations for the interim periods reported herein are not necessarily indicative of results to be expected for the full year.  We have evaluated all subsequent events through the date of the filing of this Form 10-Q. These unaudited consolidated financial statements should be read in conjunction with the financial statements and the footnotes thereto included in our latest Annual Report on Form 10-K.
	Our consolidated financial statements include the accounts of (i) Omega, (ii) all direct and indirect wholly owned subsidiaries of Omega, and (iii) TC Healthcare, a variable interest entity (“VIE”) that we consolidate as the primary beneficiary.  All inter-company accounts and transactions have been eliminated in consolidation of the financial statements.
Accounts Receivable	'
	Accounts Receivable
	Accounts receivable includes: contractual receivables, effective yield interest receivables, straight-line rent receivables and lease inducements, net of an estimated provision for losses related to uncollectible and disputed accounts.  Contractual receivables relate to the amounts currently owed to us under the terms of our lease and loan agreements.  Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement. Straight-line receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts currently due to us according to the contractual agreement.  Lease inducements result from value provided by us to the lessee at the inception or renewal of the lease and will be amortized as a reduction of rental revenue over the non cancellable lease term.
	On a quarterly basis, we review our accounts receivable to determine their collectability.  The determination of collectability of these assets requires significant judgment and is affected by several factors relating to the credit quality of our operators that we regularly monitor, including (i) payment history, (ii) the age of the contractual receivables, (iii) the current economic conditions and reimbursement environment, (iv) the ability of the tenant to perform under the terms of their lease and/or contractual loan agreements and (v) the value of the underlying collateral of the agreement.  If we determine collectability of any of our contractual receivables is at risk, we estimate the potential uncollectible amounts and provide an allowance.  In the case of a lease recognized on a straight-line basis or existence of lease inducements, we generally provide an allowance for straight-line accounts receivable and/or the lease inducements when certain conditions or indicators of adverse collectability are present.
	A summary of our net receivables by type is as follows:
		September 30,			December 31,
		2013			2012
		(in thousands)
	Contractual receivables	$	3,905		$	3,963
	Effective yield interest receivables		4,992			3,576
	Straight-line receivables		116,972			98,973
	Lease inducements		17,077			19,307
	Allowance		(520	)		(639	)
	Accounts receivable – net	$	142,426		$	125,180
	In August 2013, we entered into an agreement with one of our current operators and a new third party operator to transition 11 facilities from the current operator to the third party operator.  As a result of the transition, we evaluated the recoverability of the straight-line rent receivable associated with the current operator’s lease and recorded a $2.3 million provision for uncollectible accounts associated with straight-line receivables that were written-off.  (See Note 2 – Properties and Investments).
	We continuously evaluate the payment history and financial strength of our operators and have historically established allowance reserves for straight-line rent adjustments for operators that do not meet our requirements.  We consider factors such as payment history and the operator’s financial condition as well as current and future anticipated operating trends when evaluating whether to establish allowance reserves.

BASIS_OF_PRESENTATION_AND_SIGN2

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
Schedule of summary of net receivables	'
		September 30,			December 31,
		2013			2012
		(in thousands)
	Contractual receivables	$	3,905		$	3,963
	Effective yield interest receivables		4,992			3,576
	Straight-line receivables		116,972			98,973
	Lease inducements		17,077			19,307
	Allowance		(520	)		(639	)
	Accounts receivable – net	$	142,426		$	125,180

PROPERTIES_AND_INVESTMENTS_Tab

PROPERTIES AND INVESTMENTS (Tables)	9 Months Ended
	Sep. 30, 2013
Real Estate [Abstract]	'
Schedule of unaudited pro forma results of business acquisition	'
		Pro Forma
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2013		2012		2013		2012
		(in thousands, except per share amounts, unaudited)
	Revenues	$	103,301	$	97,892	$	307,577	$	293,244
	Net income available to common stockholders	$	38,137	$	34,703	$	125,315	$	102,571
	Earnings per share – diluted:
	Net income available to common stockholders – as reported	$	0.32	$	0.27	$	1.08	$	0.81
	Net income available to common stockholders – pro forma	$	0.32	$	0.32	$	1.08	$	0.96

OTHER_INVESTMENTS_Tables

OTHER INVESTMENTS (Tables)	9 Months Ended
	Sep. 30, 2013
Receivables [Abstract]	'
Schedule of other investments	'
			September 30,			December 31,
			2013			2012
			(in thousands)
	Other Investment note due 2015		$	2,368		$	2,518
	Other Investment notes due 2021 - 2023			13,217			9,775
	Other Investment note due 2013			551			1,018
	Other Investment note due 2014			250			812
	$28.0 Million Other Investment note due 2017			24,500			26,500
	$2.5 Million Other Investment note due 2014			306			-
	$6.0 Million Other Investment note due 2013			5,439			3,450
	Other Investment note due 2013			-			261
	$1.3 Million Other Investment note due 2017			1,300			425
	$25.0 Million Other Investment note due 2017			24,910			-
	Notes receivable, gross(1)			72,841			44,759
	Allowance for loss on notes receivable			(1,977	)		(1,977	)
	Notes receivable, net			70,864			42,782
	Marketable securities and other			4,557			4,557
	Total other investments		$	75,421		$	47,339
	-1	The majority of these notes bear interest at approximately 10% annually.

STOCKBASED_COMPENSATION_Tables

STOCK-BASED COMPENSATION (Tables)	9 Months Ended
	Sep. 30, 2013
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]	'
Schedule of stock-based compensation expense	'
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2013		2012		2013		2012
		(in thousands)
	Stock-based compensation expense	$	1,509	$	1,485	$	4,433	$	4,456
Schedule of unrecognized compensation cost associated with outstanding restricted stock and PRSU awards	'
		Shares/ Units		Grant Date		Total		Weighted		Unrecognized
				Average Fair		Compensation		Average		Compensation
				Value Per		Cost		Period of		Cost
				Unit/ Share		(in millions)		Expense Recognition		(in millions)
								(in months)
	Restricted stock		428,503	$	22.44	$	9.6		36	$	0.8
	2013 Annual PRSUs		124,244	$	8.92		1.1		12		0.3
	Multi-year absolute TSR PRSUs		279,550	$	11.06		3.1		44		0.7
	Multi-year relative TSR PRSUs		93,183	$	12.26		1.1		44		0.2
	Total		925,480	$	14.93	$	14.9			$	2

FINANCING_ACTIVITIES_AND_BORRO1

FINANCING ACTIVITIES AND BORROWING ARRANGEMENTS (Tables)	9 Months Ended
	Sep. 30, 2013
Debt Disclosure [Abstract]	'
Schedule of long-term borrowings	'
					Current			September 30,		December 31,
			Maturity		Rate			2013		2012
								(in thousands)
	Secured borrowings:
	HUD mortgages assumed June 2010			2036 - 2040		-		$	—	$	62,921
	HUD mortgages assumed June 2010 (1)			2040 - 2045		4.85	%		129,209		130,887
	HUD mortgages assumed October 2011 (1)			2036 - 2040		4.87	%		31,359		31,991
	HUD mortgages assumed December 2011(1)			2044		3.06	%		58,880		58,884
	HUD mortgages assumed December 2012(1)			2031 - 2045		5.5	%		80,586		81,855
	Total secured borrowings								300,034		366,538
	Unsecured borrowings:
	Revolving line of credit			2016		-		$	—	$	158,000
	Term loan			2017		1.93	%		200,000		100,000
									200,000		258,000
	2020 notes			2020		7.5	%		200,000		200,000
	2022 notes			2022		6.75	%		575,000		575,000
	2024 notes			2024		5.875	%		400,000		400,000
	Subordinated debt			2021		9	%		20,930		21,049
									1,195,930		1,196,049
	Premium - net								4,083		4,345
	Total unsecured borrowings								1,400,013		1,458,394
	Totals – net							$	1,700,047	$	1,824,932
		-1	Reflects the weighted average annual interest rate on the mortgages.

FINANCIAL_INSTRUMENTS_Tables

FINANCIAL INSTRUMENTS (Tables)	9 Months Ended
	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
Schedule of the carrying amounts and fair values of financial instruments	'
		30-Sep-13				31-Dec-12
		Carrying		Fair		Carrying		Fair
		Amount		Value		Amount		Value
	Assets:	(in thousands)
	Cash and cash equivalents	$	67,757	$	67,757	$	1,711	$	1,711
	Restricted cash		28,781		28,781		36,660		36,660
	Mortgage notes receivable – net		241,490		240,013		238,621		235,705
	Other investments – net		75,421		72,820		47,339		44,077
	Totals	$	413,449	$	409,371	$	324,331	$	318,153
	Liabilities:
	Revolving line of credit	$	—	$	—	$	158,000	$	158,000
	Term loan		200,000		200,000		100,000		100,000
	7.50% Notes due 2020 – net		197,805		246,304		197,546		252,363
	6.75% Notes due 2022 – net		581,278		709,601		581,799		724,240
	5.875% Notes due 2024 – net		400,000		401,492		400,000		441,761
	HUD debt		300,034		335,745		366,538		433,803
	Subordinated debt		20,930		27,153		21,049		27,896
	Totals	$	1,700,047	$	1,920,295	$	1,824,932	$	2,138,063

EARNINGS_PER_SHARE_Tables

EARNINGS PER SHARE (Tables)	9 Months Ended
	Sep. 30, 2013
Net Income Available To Common Per Share	'
Schedule of computation of basic and diluted earnings per share	'
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2013		2012		2013		2012
		(in thousands, except per share amounts)
	Numerator:
	Net income	$	38,137	$	30,119	$	125,315	$	86,775
	Numerator for net income available to common per share - basic and diluted	$	38,137	$	30,119	$	125,315	$	86,775
	Denominator:
	Denominator for basic earnings per share		117,600		109,135		115,527		106,202
	Effect of dilutive securities:
	Restricted stock		823		511		774		350
	Deferred stock		39		21		34		18
	Denominator for diluted earnings per share		118,462		109,667		116,335		106,570
	Earnings per share – basic:
	Net income – basic	$	0.32	$	0.28	$	1.08	$	0.82
	Earnings per share – diluted:
	Net income – diluted	$	0.32	$	0.27	$	1.08	$	0.81

CONSOLIDATING_FINANCIAL_STATEM1

CONSOLIDATING FINANCIAL STATEMENTS (Tables)	9 Months Ended
	Sep. 30, 2013
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]	'
Schedule of consolidating balance sheets	'
	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING BALANCE SHEETS
	Unaudited
	(in thousands, except per share amounts)
		30-Sep-13
		Issuer & Subsidiary Guarantors			Non-Guarantor Subsidiaries			Elimination Company			Consolidated
	ASSETS
	Real estate properties
	Land and buildings	$	2,602,688		$	457,500		$	-		$	3,060,188
	Less accumulated depreciation		(627,301	)		(48,384	)		-			(675,685	)
	Real estate properties – net		1,975,387			409,116			-			2,384,503
	Mortgage notes receivable – net		241,490			-			-			241,490
			2,216,877			409,116			-			2,625,993
	Other investments – net		75,421			-			-			75,421
			2,292,298			409,116			-			2,701,414
	Assets held for sale – net		1,020			-			-			1,020
	Total investments		2,293,318			409,116			-			2,702,434
	Cash and cash equivalents		67,757			-			-			67,757
	Restricted cash		6,755			22,026			-			28,781
	Accounts receivable – net		136,101			6,325			-			142,426
	Investment in affiliates		107,535			-			(107,535	)		-
	Other assets		46,829			26,551			-			73,380
	Total assets	$	2,658,295		$	464,018		$	(107,535	)	$	3,014,778
	LIABILITIES AND STOCKHOLDERS’ EQUITY
	Revolving line of credit	$	-		$	-		$	-		$	-
	Term loan		200,000			-			-			200,000
	Secured borrowings		-			300,034			-			300,034
	Unsecured borrowings – net		1,179,083			20,930			-			1,200,013
	Accrued expenses and other liabilities		89,214			35,519			-			124,733
	Intercompany payable		-			85,438			(85,438	)		-
	Total liabilities		1,468,297			441,921			(85,438	)		1,824,780
	Stockholders’ equity:
	Common stock		11,952			-			-			11,952
	Common stock – additional paid-in capital		1,876,609			-			-			1,876,609
	Cumulative net earnings		879,443			22,097			(22,097	)		879,443
	Cumulative dividends paid		(1,578,006	)		-			-			(1,578,006	)
	Total stockholders’ equity		1,189,998			22,097			(22,097	)		1,189,998
	Total liabilities and stockholders’ equity	$	2,658,295		$	464,018			(107,535	)	$	3,014,778
	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING BALANCE SHEETS
	(in thousands, except per share amounts)
		31-Dec-12
					Non – Guarantor Subsidiaries			Elimination Company
		Issuer & Subsidiary									Consolidated
		Guarantors
	ASSETS
	Real estate properties
	Land and buildings	$	2,580,977		$	457,576		$	—		$	3,038,553
	Less accumulated depreciation		(547,489	)		(32,884	)		—			(580,373	)
	Real estate properties – net		2,033,488			424,692			—			2,458,180
	Mortgage notes receivable – net		238,621			—			—			238,621
			2,272,109			424,692			—			2,696,801
	Other investments – net		47,339			—			—			47,339
			2,319,448			424,692			—			2,744,140
	Assets held for sale – net		1,020			—			—			1,020
	Total investments		2,320,468			424,692			—			2,745,160
	Cash and cash equivalents		1,711			—			—			1,711
	Restricted cash		10,095			26,565			—			36,660
	Accounts receivable – net		121,488			3,692			—			125,180
	Investment in affiliates		115,835			—			(115,835	)		—
	Other assets		49,153			24,141			—			73,294
	Total assets	$	2,618,750		$	479,090			(115,835	)	$	2,982,005
	LIABILITIES AND STOCKHOLDERS’ EQUITY
Revolving line of credit	$	158,000		$	—		$	—		$	158,000
Term loan		100,000			—			—			100,000
Secured borrowings		62,921			303,617			—			366,538
Unsecured borrowings – net		1,179,345			21,049			—			1,200,394
Accrued expenses and other liabilities		107,155			38,589			—			145,744
Intercompany payable		—			104,040			(104,040	)		—
Total liabilities		1,607,421			467,295			(104,040	)		1,970,676
Stockholders’ equity:
Common stock		11,239			—			—			11,239
Common stock – additional paid-in capital		1,664,855			—			—			1,664,855
Cumulative net earnings		754,128			11,795			(11,795	)		754,128
Cumulative dividends paid		(1,418,893	)		—			—			(1,418,893	)
Total stockholders’ equity		1,011,329			11,795			(11,795	)		1,011,329
Total liabilities and stockholders’ equity	$	2,618,750		$	479,090		$	(115,835	)	$	2,982,005
Schedule of consolidating statement of operations	'
	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING STATEMENTS OF OPERATIONS
	Unaudited
	(in thousands, except per share amounts)
														Nine Months Ended September 30, 2013
		Three Months Ended September 30, 2013
					Non – Guarantor Subsidiaries						Consolidated			Issuer & Subsidiary Guarantors			Non – Guarantor Subsidiaries						Consolidated
		Issuer & Subsidiary Guarantors
								Elimination												Elimination
	Revenue
	Rental income	$	81,289		$	12,548		$	-		$	93,837		$	242,253		$	37,762		$	-		$	280,015
	Mortgage interest income		7,289			-			-			7,289			22,070			-			-			22,070
	Other investment income – net		2,175			-			-			2,175			5,341			-			-			5,341
	Miscellaneous		-			-			-			-			151			-			-			151
	Total operating revenues		90,753			12,548			-			103,301			269,815			37,762			-			307,577
	Expenses
	Depreciation and amortization		27,034			5,168			-			32,202			80,885			15,501			-			96,386
	General and administrative		5,372			90			-			5,462			15,859			283			-			16,142
	Acquisition costs		(9	)		-			-			(9	)		134			-			-			134
	Provision for uncollectible mortgages, notes and accounts receivable		2,321			-			-			2,321			2,386			-			-			2,386
	Total operating expenses		34,718			5,258			-			39,976			99,264			15,784			-			115,048
	Income before other income and expense		56,035			7,290			-			63,325			170,551			21,978			-			192,529
	Other income (expense):
	Interest income		(4	)		7			-			3			(1	)		21			-			20
	Interest expense		(20,725	)		(3,767	)		-			(24,492	)		(63,429	)		(11,687	)		-			(75,116	)
	Interest – amortization of deferred financing costs		(694	)		(5	)		-			(699	)		(2,069	)		(10	)		-			(2,079	)
	Interest – refinancing gain (costs)		-			-			-			-			11,112			-			-			11,112
	Equity in earnings		3,525			-			(3,525	)		-			10,302			-			(10,302	)		-
	Total other expense		(17,898	)		(3,765	)		(3,525	)		(25,188	)		(44,085	)		(11,676	)		(10,302	)		(66,063	)
	Income before gain on assets sold		38,137			3,525			(3,525	)		38,137			126,466			10,302			(10,302	)		126,466
	Loss on assets sold – net		-			-			-			-			(1,151	)		-			-			(1,151	)
	Net income (loss) available to common stockholders	$	38,137		$	3,525		$	(3,525	)	$	38,137		$	125,315		$	10,302		$	(10,302	)	$	125,315
	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING STATEMENTS OF OPERATIONS
	Unaudited
	(in thousands, except per share amounts)
														Nine Months Ended September 30, 2012
		Three Months Ended September 30, 2012
					Non – Guarantor Subsidiaries						Consolidated			Issuer & Subsidiary Guarantors			Non – Guarantor Subsidiaries						Consolidated
		Issuer & Subsidiary Guarantors						Elimination												Elimination
								Company												Company
	Revenue
	Rental income	$	69,092		$	9,078		$	-		$	78,170		$	202,008		$	27,365		$	-		$	229,373
	Mortgage interest income		7,677			-			-			7,677			22,417			-			-			22,417
	Other investment income – net		1,238			-			-			1,238			3,533			-			-			3,533
	Miscellaneous		23			-			-			23			125			-			-			125
	Total operating revenues		78,030			9,078			-			87,108			228,083			27,365			-			255,448
	Expenses
	Depreciation and amortization		24,220			4,085			-			28,305			70,457			12,194			-			82,651
	General and administrative		5,090			83			-			5,173			15,390			263			-			15,653
	Acquisition costs		483			-			-			483			686			-			-			686
	Impairment loss on real estate properties		-			-			-			-			272			-			-			272
	Total operating expenses		29,793			4,168			-			33,961			86,805			12,457			-			99,262
	Income before other income and expense		48,237			4,910			-			53,147			141,278			14,908			-			156,186
	Other income (expense):
	Interest income		-			6			-			6			4			18			-			22
	Interest expense		(20,602	)		(3,448	)		-			(24,050	)		(61,290	)		(9,736	)		-			(71,026	)
	Interest – amortization of deferred financing costs		(673	)		-			-			(673	)		(1,970	)		-			-			(1,970	)
	Interest – refinancing gain (costs)		-			-			-			-			(5,410	)		-			-			(5,410	)
	Equity in earnings		1,468			-			(1,468	)		-			5,190			-			(5,190	)		-
	Total other expense		(19,807	)		(3,442	)		(1,468	)		(24,717	)		(63,476	)		(9,718	)		(5,190	)		(78,384	)
	Income before gain on assets sold		28,430			1,468			(1,468	)		28,430			77,802			5,190			(5,190	)		77,802
	Gain on assets sold – net		1,689			-			-			1,689			8,973			-			-			8,973
Net income (loss) available to common stockholders	$	30,119		$	1,468		$	(1,468	)	$	30,119		$	86,775		$	5,190		$	(5,190	)	$	86,775

BASIS_OF_PRESENTATION_AND_SIGN3

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Organization, Consolidation and Presentation Of Financial Statements [Abstract]	'	'
Contractual receivables	$3,905	$3,963
Effective yield interest receivables	4,992	3,576
Straight-line receivables	116,972	98,973
Lease inducements	17,077	19,307
Allowance	-520	-639
Accounts receivable - net	$142,426	$125,180

BASIS_OF_PRESENTATION_AND_SIGN4

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Detail)	9 Months Ended
	Sep. 30, 2013
	Segment
Real Estate Properties [Line Items]	'
Number of reportable segment	1

PROPERTIES_AND_INVESTMENTS_Det

PROPERTIES AND INVESTMENTS (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Earnings per share - diluted:	'	'	'	'
Net income available to common stockholders - as reported	$0.32	$0.27	$1.08	$0.81
Pro forma	'	'	'	'
Proforma Information [Line Items]	'	'	'	'
Revenues	$103,301	$97,892	$307,577	$293,244
Net income available to common stockholders	$38,137	$34,703	$125,315	$102,571
Earnings per share - diluted:	'	'	'	'
Net income available to common stockholders - as reported	$0.32	$0.27	$1.08	$0.81
Net income available to common stockholders - pro forma	$0.32	$0.32	$1.08	$0.96

PROPERTIES_AND_INVESTMENTS_Lea

PROPERTIES AND INVESTMENTS - Leased Property (Narrative) (Detail) (USD $)	9 Months Ended	1 Months Ended	9 Months Ended			1 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013	Aug. 30, 2013	Sep. 30, 2013	Sep. 30, 2013
	Facility	Ark Holding Company Inc	Property available for operating lease	Property available for operating lease	SNF's	SNF's	ALFs	Specialty facilities
		Property	Minimum	Maximum	Facility	Advocat Inc	Facility	Facility
						New Operator Arkansas Facilities
						Facility
						Bed
Leased Properties [Line Items]	'	'	'	'	'	'	'	'
Number of leased real estate properties	480	56	'	'	417	'	16	11
Lease term	'	'	'5 years	'15 years	'	'	'	'
Increase in the specific annual percentage over the prior year's rent	2.50%	'	'	'	'	'	'	'
Number of facilities transitioned to new third party operator	'	'	'	'	'	11	'	'
Number of operating beds	'	'	'	'	'	1,084	'	'
Expiration date of new lease	'	'	'	'	'	30-Aug-23	'	'
Provisions for uncollectible mortgages, notes and accounts receivable	'	'	'	'	'	$2.30	'	'
Sale / leaseback transaction, amount	'	525	'	'	'	'	'	'
Sale / leaseback transaction, term	'	'50-year lease	'	'	'	'	'	'
Sale / leaseback transaction, interest rate	'	10.70%	'	'	'	'	'	'
Deposits included in other assets	'	$15	'	'	'	'	'	'

PROPERTIES_AND_INVESTMENTS_Ass

PROPERTIES AND INVESTMENTS - Assets Sold or Held for Sale (Narrative) (Detail 2) (USD $)	1 Months Ended		9 Months Ended
	Jun. 30, 2013	Apr. 30, 2013	Sep. 30, 2013	Sep. 30, 2012
	Property
Real Estate Properties [Line Items]	'	'	'	'
Number of properties sold	1	'	'	'
Proceeds from sale of real estate investments	$2,200,000	$100,000	$2,288,000	$24,194,000
Loss on sale of properties	-1,200,000	'	'	'
SNF's	'	'	'	'
Real Estate Properties [Line Items]	'	'	'	'
Number of held-for-sale facilities	'	'	2	'
Number of parcels of land held-for-sale	'	'	1	'
Net book value of held-for-sale	'	'	$1,000,000	'

PROPERTIES_AND_INVESTMENTS_Mor

PROPERTIES AND INVESTMENTS - Mortgage Notes Receivables (Narrative) (Detail 3)	Sep. 30, 2013
	State
	Operator
	Facility
Real Estate Properties [Line Items]	'
Number of facilities owned	480
Number of states	34
Number of operators	48
Mortgage Receivable	'
Real Estate Properties [Line Items]	'
Number of states	5
Number of operators	5
Mortgage Receivable | Long-term care facilities	'
Real Estate Properties [Line Items]	'
Number of facilities owned	33
Mortgage Receivable | Fixed-rate mortgages	'
Real Estate Properties [Line Items]	'
Number of underlying real estate mortgages	14

OTHER_INVESTMENTS_Detail

OTHER INVESTMENTS (Detail) (USD $)	Sep. 30, 2013		Dec. 31, 2012
In Thousands, unless otherwise specified
Schedule of Investments [Line Items]	'		'
Notes receivable, gross	$72,841	[1]	$44,759	[1]
Allowance for loss on notes receivable	-1,977		-1,977
Notes receivable, net	70,864		42,782
Marketable securities and other	4,557		4,557
Other investments - net	75,421		47,339
Other Investment note due 2015	'		'
Schedule of Investments [Line Items]	'		'
Notes receivable, gross	2,368		2,518
Other Investment notes due 2021 - 2023	'		'
Schedule of Investments [Line Items]	'		'
Notes receivable, gross	13,217		9,775
Other Investment note due 2013	'		'
Schedule of Investments [Line Items]	'		'
Notes receivable, gross	551		1,018
Other Investment note due 2014	'		'
Schedule of Investments [Line Items]	'		'
Notes receivable, gross	250		812
$28.0 Million Other Investment note due 2017	'		'
Schedule of Investments [Line Items]	'		'
Notes receivable, gross	24,500		26,500
$2.5 Million Other Investment note due 2014	'		'
Schedule of Investments [Line Items]	'		'
Notes receivable, gross	306		'
$6.0 Million Other Investment note due 2013	'		'
Schedule of Investments [Line Items]	'		'
Notes receivable, gross	5,439		3,450
Other Investment note due 2013	'		'
Schedule of Investments [Line Items]	'		'
Notes receivable, gross	'		261
$1.3 Million Other Investment note due 2017	'		'
Schedule of Investments [Line Items]	'		'
Notes receivable, gross	1,300		425
$25.0 Million Other Investment note due 2017	'		'
Schedule of Investments [Line Items]	'		'
Notes receivable, gross	$24,910		'
[1]	The majority of these notes bear interest at approximately 10% annually.

OTHER_INVESTMENTS_Narrative_De

OTHER INVESTMENTS (Narrative) (Detail) (USD $)	Sep. 30, 2013	31-May-13
In Millions, unless otherwise specified
Schedule of Investments [Line Items]	'	'
Interest rate	10.00%	'
$28.0 Million Other Investment note due 2017	'	'
Schedule of Investments [Line Items]	'	'
Loan amount	$28	'
$2.5 Million Other Investment note due 2014	'	'
Schedule of Investments [Line Items]	'	'
Loan amount	2.5	'
$6.0 Million Other Investment note due 2013	'	'
Schedule of Investments [Line Items]	'	'
Loan amount	6	'
$1.3 Million Other Investment note due 2017	'	'
Schedule of Investments [Line Items]	'	'
Loan amount	1.3	'
$25.0 Million Other Investment note due 2017	'	'
Schedule of Investments [Line Items]	'	'
Loan amount	25	'
Mezzanine loan amount	'	$24.90
Interest rate on mezzanine loan	'	12.00%

CONCENTRATION_OF_RISK_Narrativ

CONCENTRATION OF RISK (Narrative) (Detail) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
	Facility		Facility
	Operator		Operator
	State		State
Concentration Risk [Line Items]	'	'	'	'	'
Number of facilities owned	480	'	480	'	'
Number of states	34	'	34	'	'
Number of operators	48	'	48	'	'
Gross investment in facilities, net of impairments and before reserve for uncollectible loans	$3,300,000,000	'	$3,300,000,000	'	'
Percentage share of real estate investments related to long-term care facilities	99.00%	'	99.00%	'	'
Miscellaneous investments, net	75,421,000	'	75,421,000	'	47,339,000
Operated, concentration percent for separate disclosure	10.00%	'	10.00%	'	'
Operated, concentration number	2	'	2	'	'
Revenues from operations	103,301,000	87,108,000	307,577,000	255,448,000	'
Revenues from operations, percentage	10.00%	'	10.00%	'	'
Florida	'	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'	'
Concentration percent by state	18.00%	'	18.00%	'	'
Ohio	'	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'	'
Concentration percent by state	11.00%	'	11.00%	'	'
Indiana	'	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'	'
Concentration percent by state	10.00%	'	10.00%	'	'
Genesis Healthcare	'	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'	'
Operated, concentration percent	11.00%	'	11.00%	'	'
Revenues from operations	13,800,000	'	41,400,000	'	'
Revenues from operations, percentage	13.00%	'	13.00%	'	'
CommuniCare	'	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'	'
Operated, concentration percent	10.00%	'	10.00%	'	'
Revenues from operations	$11,000,000	'	$33,100,000	'	'
Revenues from operations, percentage	11.00%	'	11.00%	'	'
SNF's	'	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'	'
Number of facilities owned	417	'	417	'	'
Number of facilities held-for-sale/closed	3	'	3	'	'
Number of facilities under fixed rate mortgage loan	33	'	33	'	'
ALFs	'	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'	'
Number of facilities owned	16	'	16	'	'
Specialty facilities	'	'	'	'	'
Concentration Risk [Line Items]	'	'	'	'	'
Number of facilities owned	11	'	11	'	'

DIVIDENDS_Narrative_Detail

DIVIDENDS (Narrative) (Detail) (USD $)	0 Months Ended			3 Months Ended		9 Months Ended		0 Months Ended
	Jul. 16, 2013	Apr. 16, 2013	Jan. 16, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Oct. 15, 2013
								Subsequent Event
Dividends [Line Items]	'	'	'	'	'	'	'	'
Common stock dividend declared, per share	$0.47	$0.46	$0.45	$0.47	$0.42	$1.38	$1.25	$0.48
Increase in quarterly common dividend, per share	$0.01	$0.01	$0.01	'	'	'	'	$0.01
Dividends declared, date of declaration	16-Jul-13	16-Apr-13	16-Jan-13	'	'	'	'	15-Oct-13
Dividends declared, date of payment	15-Aug-13	15-May-13	15-Feb-13	'	'	'	'	15-Nov-13
Dividends declared, date of record	31-Jul-13	30-Apr-13	31-Jan-13	'	'	'	'	31-Oct-13

TAXES_Narrative_Detail

TAXES (Narrative) (Detail) (USD $)	Sep. 30, 2013
In Millions, unless otherwise specified
Income Tax Disclosure [Abstract]	'
Permitted ownership of a taxable REIT subsidiary ("TRS"), maximum percentage	100.00%
Net operating loss carry-forward	$1

STOCKBASED_COMPENSATION_Detail

STOCK-BASED COMPENSATION (Detail 1) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]	'	'	'	'
Stock-based compensation expense	$1,509	$1,485	$4,433	$4,456

STOCKBASED_COMPENSATION_Detail1

STOCK-BASED COMPENSATION (Detail 2) (USD $)	9 Months Ended
In Millions, except Share data, unless otherwise specified	Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Shares/Units	925,480
Grant Date Average Fair Value Per Unit/ Share	$14.93
Total Compensation Cost	$14.90
Unrecognized Compensation Cost	2
Restricted stock	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Shares/Units	428,503
Grant Date Average Fair Value Per Unit/ Share	$22.44
Total Compensation Cost	9.6
Weighted Average Period of Expense Recognition	'36 months
Unrecognized Compensation Cost	0.8
Performance restricted stock units | 2013 Annual PRSUs	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Shares/Units	124,244
Grant Date Average Fair Value Per Unit/ Share	$8.92
Total Compensation Cost	1.1
Weighted Average Period of Expense Recognition	'12 months
Unrecognized Compensation Cost	0.3
Performance restricted stock units | Multi-year absolute TSR PRSUs	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Shares/Units	279,550
Grant Date Average Fair Value Per Unit/ Share	$11.06
Total Compensation Cost	3.1
Weighted Average Period of Expense Recognition	'44 months
Unrecognized Compensation Cost	0.7
Performance restricted stock units | Multi-year relative TSR PRSUs	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Shares/Units	93,183
Grant Date Average Fair Value Per Unit/ Share	$12.26
Total Compensation Cost	1.1
Weighted Average Period of Expense Recognition	'44 months
Unrecognized Compensation Cost	$0.20

STOCKBASED_COMPENSATION_Narrat

STOCK-BASED COMPENSATION (Narrative) (Detail 1)

Jun. 06, 2013

Jan. 31, 2013

Jan. 31, 2012

Jan. 31, 2011

Sep. 30, 2013

Sep. 30, 2013

Dec. 31, 2011

Sep. 30, 2013

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Jan. 31, 2011

Sep. 30, 2013

2013 Plan

Performance restricted stock units

Performance restricted stock units

Performance restricted stock units

Performance restricted stock units

Performance restricted stock units

Performance restricted stock units

Performance restricted stock units

Performance restricted stock units

Performance restricted stock units

Performance restricted stock units

Restricted stock

Restricted stock

Employee

Employee

Employee

Multi-year absolute TSR PRSUs

Multi-year absolute TSR PRSUs

Multi-year relative TSR PRSUs

Multi-year relative TSR PRSUs

Annual TSR

Annual TSR

Employee

Employee

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of shares reserved for issuance

3,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Number of shares granted

'

124,244

124,244

496,977

'

'

279,550

'

93,183

'

124,244

428,503

'

Performance based restricted stock granted, number of employees

'

6

6

6

'

'

'

'

'

'

6

6

'

Stock awards, vesting percent

'

'

'

'

'

25.00%

'

25.00%

'

'

'

'

100.00%

Stock awards, vesting date

'

'

'

'

'

'

'

'

'

'

'

'

31-Dec-13

Stock awards, vesting year

'

'

'

'

'

'2014

'

'2014

'

'

'

'

'

Shares of stock vested

'

'

'

'

'

'

'

'

'

124,244

'

'

'

Shares forfeited

'

'

'

'

'

'

'

'

'

'

124,244

'

'

Method used to estimate the fair value for PRSUs

'

'

'

'

'Monte Carlo model

'

'

'

'

'

'

'

'

STOCKBASED_COMPENSATION_Narrat1

STOCK-BASED COMPENSATION (Narrative) (Detail 2) (USD $)	9 Months Ended
In Millions, except Share data, unless otherwise specified	Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Shares of restricted stock outstanding	925,480
Restricted stock	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Shares of restricted stock outstanding	428,503
Restricted stock | Directors	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Shares of restricted stock outstanding	43,457
Vesting period, years	'3 years
Unrecognized compensation cost	$0.50

FINANCING_ACTIVITIES_AND_BORRO2

FINANCING ACTIVITIES AND BORROWING ARRANGEMENTS - Long-term borrowings (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013		Dec. 31, 2012
Debt Instrument [Line Items]	'		'
Current Rate	10.00%		'
HUD debt	$300,034		$366,538
Revolving line of credit	'		158,000
Term loan	200,000		100,000
Revolving line of credit including term loan	200,000		258,000
Totals - net	1,700,047		1,824,932
2020 notes	'		'
Debt Instrument [Line Items]	'		'
Senior notes outstanding	200,000		'
2022 notes	'		'
Debt Instrument [Line Items]	'		'
Senior notes outstanding	575,000		'
2024 notes	'		'
Debt Instrument [Line Items]	'		'
Senior notes outstanding	400,000		'
Secured borrowings | HUD mortgages assumed June 2010	'		'
Debt Instrument [Line Items]	'		'
Maturity	'2036 - 2040		'
Current Rate	'		'
Long-term borrowing amount, secured borrowings	'		62,921
Secured borrowings | HUD mortgages assumed June 2010	'		'
Debt Instrument [Line Items]	'		'
Maturity	'2040 - 2045	[1]	'
Current Rate	4.85%	[1]	'
Long-term borrowing amount, secured borrowings	129,209	[1]	130,887	[1]
Secured borrowings | HUD mortgages assumed October 2011	'		'
Debt Instrument [Line Items]	'		'
Maturity	'2036 - 2040	[1]	'
Current Rate	4.87%	[1]	'
Long-term borrowing amount, secured borrowings	31,359	[1]	31,991	[1]
Secured borrowings | HUD mortgages assumed December 2011	'		'
Debt Instrument [Line Items]	'		'
Maturity	'2044	[1]	'
Current Rate	3.06%	[1]	'
Long-term borrowing amount, secured borrowings	58,880	[1]	58,884	[1]
Secured borrowings | HUD mortgages assumed December 2012	'		'
Debt Instrument [Line Items]	'		'
Maturity	'2031 - 2045	[1]	'
Current Rate	5.50%	[1]	'
Long-term borrowing amount, secured borrowings	80,586	[1]	81,855	[1]
Unsecured borrowings	'		'
Debt Instrument [Line Items]	'		'
Unsecured borrowing	1,195,930		1,196,049
Premium - net	4,083		4,345
Total unsecured borrowings	1,400,013		1,458,394
Unsecured borrowings | Revolving line of credit	'		'
Debt Instrument [Line Items]	'		'
Maturity	'2016		'
Current Rate	'		'
Revolving line of credit	'		158,000
Unsecured borrowings | Term loan	'		'
Debt Instrument [Line Items]	'		'
Maturity	'2017		'
Current Rate	1.93%		'
Term loan	200,000		100,000
Unsecured borrowings | 2020 notes	'		'
Debt Instrument [Line Items]	'		'
Maturity	'2020		'
Current Rate	7.50%		'
Senior notes outstanding	200,000		200,000
Unsecured borrowings | 2022 notes	'		'
Debt Instrument [Line Items]	'		'
Maturity	'2022		'
Current Rate	6.75%		'
Senior notes outstanding	575,000		575,000
Unsecured borrowings | 2024 notes	'		'
Debt Instrument [Line Items]	'		'
Maturity	'2024		'
Current Rate	5.88%		'
Senior notes outstanding	400,000		400,000
Unsecured borrowings | Subordinated debt	'		'
Debt Instrument [Line Items]	'		'
Maturity	'2021		'
Current Rate	9.00%		'
Subordinated debt	$20,930		$21,049
[1]	Reflects the weighted average annual interest rate on the mortgages.

FINANCING_ACTIVITIES_AND_BORRO3

FINANCING ACTIVITIES AND BORROWING ARRANGEMENTS - Long-term borrowings (Detail) - Unsecured Borrowings (Narrative) (Detail 1) (USD $)

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Dec. 06, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Dec. 06, 2012

Sep. 30, 2013

Sep. 30, 2013

Dec. 06, 2012

Dec. 06, 2012

Sep. 30, 2013

Dec. 31, 2012

Unsecured borrowings

Unsecured borrowings

Unsecured borrowings

Unsecured borrowings

Unsecured borrowings

Unsecured borrowings

Unsecured borrowings

Unsecured borrowings

Unsecured borrowings

Unsecured borrowings

Unsecured borrowings

Unsecured borrowings

2012 Revolving Credit Facility

2012 Revolving Credit Facility

2012 Revolving Credit Facility

2012 Revolving Credit Facility

2012 Term Loan Facility

2012 Term Loan Facility

2012 Term Loan Facility

2012 Term Loan Facility

2012 Credit Facilities

2012 Credit Facilities

Term loan

Term loan

Minimum

Maximum

Minimum

Maximum

Maximum

Borrowing Arrangements [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Credit facility, borrowing capacity

'

'

'

$500,000,000

'

'

'

$200,000,000

'

'

$700,000,000

'

'

'

Credit facility, potential borrowing capacity

'

'

'

'

'

'

'

'

'

'

300,000,000

1,000,000,000

'

'

Line of credit remaining borrowing capacity

'

'

500,000,000

'

'

'

'

'

'

'

'

'

'

'

Term loan

200,000,000

100,000,000

'

'

'

'

'

'

'

'

'

'

200,000,000

100,000,000

Revolving line of credit

'

$158,000,000

'

'

'

'

$200,000,000

'

'

'

'

'

'

'

Pricing of credit facility at LIBOR plus an applicable percentage

'

'

1.50%

'

1.00%

1.90%

1.75%

'

1.10%

2.30%

'

'

'

'

Credit facility, description of variable rate basis

'

'

'The 2012 Revolving Credit Facility is priced at LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 190 basis points) based on our ratings from Standard & Poor's, Moody's and/or Fitch Ratings

'

'

'

'The 2012 Term Loan Facility is also priced at LIBOR plus an applicable percentage (beginning at 175 basis points, with a range of 110 to 230 basis points) based our ratings from Standard & Poor's, Moody's and/or Fitch Ratings

'

'

'

'

'

'

'

Facility fee, basis spread on variable rate

'

'

0.30%

'

0.15%

0.45%

'

'

'

'

'

'

'

'

Facility fee, description of variable rate basis

'

'

'facility fee based on the same ratings (initially 30 basis points, with a range of 15 to 45 basis points)

'

'

'

'

'

'

'

'

'

'

'

Debt maturity date

'

'

6-Dec-16

'

'

'

6-Dec-17

'

'

'

'

'

'

'

FINANCING_ACTIVITIES_AND_BORRO4

FINANCING ACTIVITIES AND BORROWING ARRANGEMENTS (Narrative) (Detail 2) (USD $)	3 Months Ended	9 Months Ended		1 Months Ended	3 Months Ended	9 Months Ended	1 Months Ended	3 Months Ended	1 Months Ended	3 Months Ended	1 Months Ended
Share data in Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2012	Mar. 18, 2013	Sep. 30, 2013	Sep. 30, 2013	Mar. 18, 2013	Mar. 31, 2013	Mar. 26, 2013	Mar. 31, 2013	31-May-13
				$250 Million Equity Shelf Program	$250 Million Equity Shelf Program	$250 Million Equity Shelf Program	Termination of $245 Million Equity Shelf Program	Termination of $245 Million Equity Shelf Program	HUD Mortgage Debt Refinancing	HUD Mortgage Debt Refinancing	Hud loans payoff
										Property	HUD_Mortgage
Debt Instrument [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Principal payment for mortgage	'	'	'	'	'	'	'	'	$59,400,000	$58,900,000	'
Number of Arkansas mortgage debts paid off	'	'	'	'	'	'	'	'	'	12	'
Weighted average annual interest rate	'	'	'	'	'	'	'	'	5.55%	'	'
Reduction in annual interest rate for the refinanced debt	'	'	'	'	'	'	'	'	3.06%	'	'
Sales price, equity distribution agreement	'	'	'	250,000,000	'	'	245,000,000	'	'	'	'
Stock issued	'	5,428	'	'	2,100	4,400	3,600	1,000	'	'	'
Average price per share (in dollars per share)	$29.03	$28.53	'	'	$29.42	$30.61	'	$28.29	'	'	'
Gross proceeds from issue of common stock, before commissions	'	'	'	'	63,200,000	136,000,000	91,400,000	27,800,000	'	'	'
Commissions on sale of common stock	'	'	'	'	1,300,000	2,700,000	1,900,000	600,000	'	'	'
Shares issued through Dividend Reinvestment Plan and Common Stock Purchase Program	200	1,700	'	'	'	'	'	'	'	'	'
Net proceeds from shares issued under Dividend Reinvestment and Common Stock Purchase Program	6,200,000	47,821,000	106,132,000	'	'	'	'	'	'	'	'
Manager compensation, percentage of gross sales price per share sold	'	'	'	2.00%	'	'	'	'	'	'	'
Payment to retire HUD mortgages	'	'	'	'	'	'	'	'	'	'	51,000,000
Number of HUD mortgages	'	'	'	'	'	'	'	'	'	'	11
Gain on retirement of HUD mortgages	'	'	'	'	'	'	'	'	'	'	11,100,000
Unamortized premium	'	'	'	'	'	'	'	'	'	'	11,300,000
Prepayment fee	'	'	'	'	'	'	'	'	'	'	$200,000

FINANCIAL_INSTRUMENTS_Detail

FINANCIAL INSTRUMENTS (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Assets:	'	'	'	'
Cash and cash equivalents	$67,757	$1,711	$6,951	$351
Restricted cash	28,781	36,660	'	'
Mortgage notes receivable - net	241,490	238,621	'	'
Other investments - net	75,421	47,339	'	'
Liabilities:	'	'	'	'
Revolving line of credit	'	158,000	'	'
Term loan	200,000	100,000	'	'
HUD debt	300,034	366,538	'	'
Carrying Amount	'	'	'	'
Assets:	'	'	'	'
Cash and cash equivalents	67,757	1,711	'	'
Restricted cash	28,781	36,660	'	'
Mortgage notes receivable - net	241,490	238,621	'	'
Other investments - net	75,421	47,339	'	'
Totals	413,449	324,331	'	'
Liabilities:	'	'	'	'
Revolving line of credit	'	158,000	'	'
Term loan	200,000	100,000	'	'
HUD debt	300,034	366,538	'	'
Subordinated debt	20,930	21,049	'	'
Totals	1,700,047	1,824,932	'	'
Carrying Amount | 7.50% Notes due 2020	'	'	'	'
Liabilities:	'	'	'	'
Notes Payable	197,805	197,546	'	'
Carrying Amount | 6.75% Notes due 2022	'	'	'	'
Liabilities:	'	'	'	'
Notes Payable	581,278	581,799	'	'
Carrying Amount | 5.875% Notes due 2024	'	'	'	'
Liabilities:	'	'	'	'
Notes Payable	400,000	400,000	'	'
Fair Value	'	'	'	'
Assets:	'	'	'	'
Cash and cash equivalents	67,757	1,711	'	'
Restricted cash	28,781	36,660	'	'
Mortgage notes receivable - net	240,013	235,705	'	'
Other investments - net	72,820	44,077	'	'
Totals	409,371	318,153	'	'
Liabilities:	'	'	'	'
Revolving line of credit	'	158,000	'	'
Term loan	200,000	100,000	'	'
HUD debt	335,745	433,803	'	'
Subordinated debt	27,153	27,896	'	'
Totals	1,920,295	2,138,063	'	'
Fair Value | 7.50% Notes due 2020	'	'	'	'
Liabilities:	'	'	'	'
Notes Payable	246,304	252,363	'	'
Fair Value | 6.75% Notes due 2022	'	'	'	'
Liabilities:	'	'	'	'
Notes Payable	709,601	724,240	'	'
Fair Value | 5.875% Notes due 2024	'	'	'	'
Liabilities:	'	'	'	'
Notes Payable	$401,492	$441,761	'	'

EARNINGS_PER_SHARE_Detail

EARNINGS PER SHARE (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Numerator:	'	'	'	'
Net income	$38,137	$30,119	$125,315	$86,775
Numerator for net income available to common per share - basic and diluted	$38,137	$30,119	$125,315	$86,775
Denominator:	'	'	'	'
Denominator for basic earnings per share	117,600	109,135	115,527	106,202
Effect of dilutive securities:	'	'	'	'
Restricted stock	823	511	774	350
Deferred stock	39	21	34	18
Denominator for diluted earnings per share	118,462	109,667	116,335	106,570
Earnings per share - basic:	'	'	'	'
Net income - basic	$0.32	$0.28	$1.08	$0.82
Earnings per share - diluted:	'	'	'	'
Net income - diluted	$0.32	$0.27	$1.08	$0.81

CONSOLIDATING_FINANCIAL_STATEM2

CONSOLIDATING FINANCIAL STATEMENTS (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Real estate properties	'	'	'	'
Land and buildings	$3,060,188	$3,038,553	'	'
Less accumulated depreciation	-675,685	-580,373	'	'
Real estate properties - net	2,384,503	2,458,180	'	'
Mortgage notes receivable - net	241,490	238,621	'	'
Real estate properties, total	2,625,993	2,696,801	'	'
Other investments - net	75,421	47,339	'	'
Total investments held, continuing operations	2,701,414	2,744,140	'	'
Assets held for sale - net	1,020	1,020	'	'
Total investments	2,702,434	2,745,160	'	'
Cash and cash equivalents	67,757	1,711	6,951	351
Restricted cash	28,781	36,660	'	'
Accounts receivable - net	142,426	125,180	'	'
Investment in affiliates	'	'	'	'
Other assets	73,380	73,294	'	'
Total assets	3,014,778	2,982,005	'	'
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'	'	'
Revolving line of credit	'	158,000	'	'
Term loan	200,000	100,000	'	'
Secured borrowings	300,034	366,538	'	'
Unsecured borrowings - net	1,200,013	1,200,394	'	'
Accrued expenses and other liabilities	124,733	145,744	'	'
Intercompany payable	'	'	'	'
Total liabilities	1,824,780	1,970,676	'	'
Stockholders' equity:	'	'	'	'
Common stock	11,952	11,239	'	'
Common stock - additional paid-in capital	1,876,609	1,664,855	'	'
Cumulative net earnings	879,443	754,128	'	'
Cumulative dividends paid	-1,578,006	-1,418,893	'	'
Total stockholders' equity	1,189,998	1,011,329	'	'
Total liabilities and stockholders' equity	3,014,778	2,982,005	'	'
Issuer & Subsidiary Guarantors	'	'	'	'
Real estate properties	'	'	'	'
Land and buildings	2,602,688	2,580,977	'	'
Less accumulated depreciation	-627,301	-547,489	'	'
Real estate properties - net	1,975,387	2,033,488	'	'
Mortgage notes receivable - net	241,490	238,621	'	'
Real estate properties, total	2,216,877	2,272,109	'	'
Other investments - net	75,421	47,339	'	'
Total investments held, continuing operations	2,292,298	2,319,448	'	'
Assets held for sale - net	1,020	1,020	'	'
Total investments	2,293,318	2,320,468	'	'
Cash and cash equivalents	67,757	1,711	'	'
Restricted cash	6,755	10,095	'	'
Accounts receivable - net	136,101	121,488	'	'
Investment in affiliates	107,535	115,835	'	'
Other assets	46,829	49,153	'	'
Total assets	2,658,295	2,618,750	'	'
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'	'	'
Revolving line of credit	'	158,000	'	'
Term loan	200,000	100,000	'	'
Secured borrowings	'	62,921	'	'
Unsecured borrowings - net	1,179,083	1,179,345	'	'
Accrued expenses and other liabilities	89,214	107,155	'	'
Intercompany payable	'	'	'	'
Total liabilities	1,468,297	1,607,421	'	'
Stockholders' equity:	'	'	'	'
Common stock	11,952	11,239	'	'
Common stock - additional paid-in capital	1,876,609	1,664,855	'	'
Cumulative net earnings	879,443	754,128	'	'
Cumulative dividends paid	-1,578,006	-1,418,893	'	'
Total stockholders' equity	1,189,998	1,011,329	'	'
Total liabilities and stockholders' equity	2,658,295	2,618,750	'	'
Non-guarantor subsidiaries	'	'	'	'
Real estate properties	'	'	'	'
Land and buildings	457,500	457,576	'	'
Less accumulated depreciation	-48,384	-32,884	'	'
Real estate properties - net	409,116	424,692	'	'
Mortgage notes receivable - net	'	'	'	'
Real estate properties, total	409,116	424,692	'	'
Other investments - net	'	'	'	'
Total investments held, continuing operations	409,116	424,692	'	'
Assets held for sale - net	'	'	'	'
Total investments	409,116	424,692	'	'
Cash and cash equivalents	'	'	'	'
Restricted cash	22,026	26,565	'	'
Accounts receivable - net	6,325	3,692	'	'
Investment in affiliates	'	'	'	'
Other assets	26,551	24,141	'	'
Total assets	464,018	479,090	'	'
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'	'	'
Revolving line of credit	'	'	'	'
Term loan	'	'	'	'
Secured borrowings	300,034	303,617	'	'
Unsecured borrowings - net	20,930	21,049	'	'
Accrued expenses and other liabilities	35,519	38,589	'	'
Intercompany payable	85,438	104,040	'	'
Total liabilities	441,921	467,295	'	'
Stockholders' equity:	'	'	'	'
Common stock	'	'	'	'
Common stock - additional paid-in capital	'	'	'	'
Cumulative net earnings	22,097	11,795	'	'
Cumulative dividends paid	'	'	'	'
Total stockholders' equity	22,097	11,795	'	'
Total liabilities and stockholders' equity	464,018	479,090	'	'
Elimination Company	'	'	'	'
Real estate properties	'	'	'	'
Land and buildings	'	'	'	'
Less accumulated depreciation	'	'	'	'
Real estate properties - net	'	'	'	'
Mortgage notes receivable - net	'	'	'	'
Real estate properties, total	'	'	'	'
Other investments - net	'	'	'	'
Total investments held, continuing operations	'	'	'	'
Assets held for sale - net	'	'	'	'
Total investments	'	'	'	'
Cash and cash equivalents	'	'	'	'
Restricted cash	'	'	'	'
Accounts receivable - net	'	'	'	'
Investment in affiliates	-107,535	-115,835	'	'
Other assets	'	'	'	'
Total assets	-107,535	-115,835	'	'
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'	'	'
Revolving line of credit	'	'	'	'
Term loan	'	'	'	'
Secured borrowings	'	'	'	'
Unsecured borrowings - net	'	'	'	'
Accrued expenses and other liabilities	'	'	'	'
Intercompany payable	-85,438	-104,040	'	'
Total liabilities	-85,438	-104,040	'	'
Stockholders' equity:	'	'	'	'
Common stock	'	'	'	'
Common stock - additional paid-in capital	'	'	'	'
Cumulative net earnings	-22,097	-11,795	'	'
Cumulative dividends paid	'	'	'	'
Total stockholders' equity	-22,097	-11,795	'	'
Total liabilities and stockholders' equity	($107,535)	($115,835)	'	'

CONSOLIDATING_FINANCIAL_STATEM3

CONSOLIDATING FINANCIAL STATEMENTS (Detail 1) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenue	'	'	'	'
Rental income	$93,837	$78,170	$280,015	$229,373
Mortgage interest income	7,289	7,677	22,070	22,417
Other investment income - net	2,175	1,238	5,341	3,533
Miscellaneous	'	23	151	125
Total operating revenues	103,301	87,108	307,577	255,448
Expenses	'	'	'	'
Depreciation and amortization	32,202	28,305	96,386	82,651
General and administrative	5,462	5,173	16,142	15,653
Acquisition costs	-9	483	134	686
Provisions for uncollectible mortgages, notes and accounts receivable	2,321	'	2,386	'
Impairment on real estate properties	'	'	'	272
Total operating expenses	39,976	33,961	115,048	99,262
Income before other income and expense	63,325	53,147	192,529	156,186
Other income (expense)	'	'	'	'
Interest income	3	6	20	22
Interest expense	-24,492	-24,050	-75,116	-71,026
Interest - amortization of deferred financing costs	-699	-673	-2,079	-1,970
Interest - refinancing gain (costs)	'	'	11,112	-5,410
Equity in earnings	'	'	'	'
Total other expense	-25,188	-24,717	-66,063	-78,384
Income before gain on assets sold	38,137	28,430	126,466	77,802
Loss (Gain) on assets sold - net	'	1,689	-1,151	8,973
Net income available to common stockholders	38,137	30,119	125,315	86,775
Issuer & Subsidiary Guarantors	'	'	'	'
Revenue	'	'	'	'
Rental income	81,289	69,092	242,253	202,008
Mortgage interest income	7,289	7,677	22,070	22,417
Other investment income - net	2,175	1,238	5,341	3,533
Miscellaneous	'	23	151	125
Total operating revenues	90,753	78,030	269,815	228,083
Expenses	'	'	'	'
Depreciation and amortization	27,034	24,220	80,885	70,457
General and administrative	5,372	5,090	15,859	15,390
Acquisition costs	-9	483	134	686
Provisions for uncollectible mortgages, notes and accounts receivable	2,321	'	2,386	'
Impairment on real estate properties	'	'	'	272
Total operating expenses	34,718	29,793	99,264	86,805
Income before other income and expense	56,035	48,237	170,551	141,278
Other income (expense)	'	'	'	'
Interest income	-4	'	-1	4
Interest expense	-20,725	-20,602	-63,429	-61,290
Interest - amortization of deferred financing costs	-694	-673	-2,069	-1,970
Interest - refinancing gain (costs)	'	'	11,112	-5,410
Equity in earnings	3,525	1,468	10,302	5,190
Total other expense	-17,898	-19,807	-44,085	-63,476
Income before gain on assets sold	38,137	28,430	126,466	77,802
Loss (Gain) on assets sold - net	'	1,689	-1,151	8,973
Net income available to common stockholders	38,137	30,119	125,315	86,775
Non-guarantor subsidiaries	'	'	'	'
Revenue	'	'	'	'
Rental income	12,548	9,078	37,762	27,365
Mortgage interest income	'	'	'	'
Other investment income - net	'	'	'	'
Miscellaneous	'	'	'	'
Total operating revenues	12,548	9,078	37,762	27,365
Expenses	'	'	'	'
Depreciation and amortization	5,168	4,085	15,501	12,194
General and administrative	90	83	283	263
Acquisition costs	'	'	'	'
Provisions for uncollectible mortgages, notes and accounts receivable	'	'	'	'
Impairment on real estate properties	'	'	'	'
Total operating expenses	5,258	4,168	15,784	12,457
Income before other income and expense	7,290	4,910	21,978	14,908
Other income (expense)	'	'	'	'
Interest income	7	6	21	18
Interest expense	-3,767	-3,448	-11,687	-9,736
Interest - amortization of deferred financing costs	-5	'	-10	'
Interest - refinancing gain (costs)	'	'	'	'
Equity in earnings	'	'	'	'
Total other expense	-3,765	-3,442	-11,676	-9,718
Income before gain on assets sold	3,525	1,468	10,302	5,190
Loss (Gain) on assets sold - net	'	'	'	'
Net income available to common stockholders	3,525	1,468	10,302	5,190
Elimination Company	'	'	'	'
Revenue	'	'	'	'
Rental income	'	'	'	'
Mortgage interest income	'	'	'	'
Other investment income - net	'	'	'	'
Miscellaneous	'	'	'	'
Total operating revenues	'	'	'	'
Expenses	'	'	'	'
Depreciation and amortization	'	'	'	'
General and administrative	'	'	'	'
Acquisition costs	'	'	'	'
Provisions for uncollectible mortgages, notes and accounts receivable	'	'	'	'
Impairment on real estate properties	'	'	'	'
Total operating expenses	'	'	'	'
Income before other income and expense	'	'	'	'
Other income (expense)	'	'	'	'
Interest income	'	'	'	'
Interest expense	'	'	'	'
Interest - amortization of deferred financing costs	'	'	'	'
Interest - refinancing gain (costs)	'	'	'	'
Equity in earnings	-3,525	-1,468	-10,302	-5,190
Total other expense	-3,525	-1,468	-10,302	-5,190
Income before gain on assets sold	-3,525	-1,468	-10,302	-5,190
Loss (Gain) on assets sold - net	'	'	'	'
Net income available to common stockholders	($3,525)	($1,468)	($10,302)	($5,190)

CONSOLIDATING_FINANCIAL_STATEM4

CONSOLIDATING FINANCIAL STATEMENTS (Narrative) (Detail) (USD $)

9 Months Ended

1 Months Ended

9 Months Ended

9 Months Ended

1 Months Ended

3 Months Ended

Sep. 30, 2013

Sep. 30, 2012

Jun. 29, 2010

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

31-May-13

Sep. 30, 2013

Jul. 31, 2013

Dec. 31, 2012

Jul. 31, 2012

Dec. 31, 2011

Sep. 30, 2013

Mar. 26, 2013

Mar. 31, 2013

Non-guarantor subsidiaries

Non-guarantor subsidiaries

CapitalSource

7.50% Notes due 2020

6.75% Notes due 2022

5.875% Notes due 2024

HUD debt

HUD debt

HUD debt

HUD debt

HUD debt

HUD debt

HUD debt

HUD Mortgage Debt Refinancing

HUD Mortgage Debt Refinancing

Non-guarantor subsidiaries

HUD_Mortgage

Non-guarantor subsidiaries

Non-guarantor subsidiaries

Non-guarantor subsidiaries

Non-guarantor subsidiaries

Non-guarantor subsidiaries

Guarantor subsidiaries

Property

Subsidiary

Subsidiary

Subsidiary

Subsidiary

Subsidiary

Condensed Financial Statements, Captions [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Senior notes, principal amount

'

'

'

$200,000,000

$575,000,000

$400,000,000

'

'

'

'

'

'

'

'

'

Rate on senior notes

'

'

'

7.50%

6.75%

5.88%

'

'

'

'

'

'

'

'

'

Number of subsidiaries acquired and designated as unrestricted

'

'

39

'

'

'

'

'

'

8

'

20

'

'

'

Number of unrestricted subsidiaries removed due to retirement of HUD related mortgages

'

'

'

'

'

'

'

'

11

'

5

'

'

'

'

Principal payment for mortgage

3,400,000

2,300,000

'

'

'

'

51,000,000

'

'

'

'

'

'

59,400,000

58,900,000

Closing cost

'

'

'

'

'

'

'

'

'

'

'

'

'

'

500,000

Ownership percent of the subsidiary guarantors (in percent)

'

'

'

'

'

'

'

100.00%

'

'

'

'

100.00%

'

'

Number of Arkansas mortgage debts paid off

'

'

'

'

'

'

'

'

'

'

'

'

'

'

12

Number of HUD mortgages

'

'

'

'

'

'

11

'

'

'

'

'

'

'

'

Payment to retire HUD mortgages

'

'

'

'

'

'

62,300,000

'

'

'

'

'

'

'

'

Unamortized premium

'

'

'

'

'

'

11,300,000

'

'

'

'

'

'

'

'

Prepayment fee

'

'

'

'

'

'

$200,000

'

'

'

'

'

'

'

'

SUBSEQUENT_EVENTS_Detail

SUBSEQUENT EVENTS (Detail) (USD $)	9 Months Ended	0 Months Ended	1 Months Ended
Share data in Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Oct. 07, 2013	Oct. 31, 2013	Oct. 31, 2013	Oct. 31, 2013	Oct. 31, 2013	Oct. 31, 2013
	Operator	Subsequent Event	Subsequent Event	Subsequent Event	Subsequent Event	Subsequent Event	Subsequent Event
			Property	Florida	Indiana	SNF's	ALFs
			Operator	Bed	Bed	Indiana	Florida
						Property	Property
Subsequent Event [Line Items]	'	'	'	'	'	'	'
Investment in facility	'	'	$33,000,000	'	'	'	'
Number of real estate properties acquired	'	'	'	'	'	4	1
Number of acquisition completed	'	'	2	'	'	'	'
Number of existing operators	48	'	2	'	'	'	'
Number of operating beds	'	'	'	97	384	'	'
Shares of common stock issued in an underwritten public offering	5,428	2,875	'	'	'	'	'
Shares of common stock issued in an underwritten public offering, price per share	'	$30	'	'	'	'	'
Proceeds from shares of common stock issued in an underwritten public offering	$160,159,000	$84,500,000	'	'	'	'	'